Steven G Potkin

Title(s)Professor Emeritus, Psychiatry
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    CSF-enhanced-aggregation biomarker for Huntingtons disease
    NIH U01NS087825Sep 1, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SchizConnect: Large-Scale Schizophrenia Neuroimaging Data Mediation & Federation
    NIH U01MH097435Mar 19, 2013 - Jan 31, 2018
    Role: Co-Principal Investigator
    2/2-Antipsychotic Effects of Oxytocin
    NIH R34MH091286Jul 11, 2011 - Jun 30, 2014
    Role: Principal Investigator
    Function BIRN
    NIH U24RR021992Feb 8, 2006 - Jul 31, 2013
    Role: Principal Investigator
    Transdisciplinary Imaging Genetics Center (1 of 2)(RMI)
    NIH P20RR020837Sep 28, 2004 - Jul 31, 2009
    Role: Principal Investigator
    CLINICAL CROSS-CULTURAL MENTAL HEALTH SERVICES RESEARCH
    NIH R24MH053808Sep 30, 1994 - Aug 31, 2001
    Role: Principal Investigator
    TREATMENT-RESISTANT SCHIZOPHRENIA: PET AND EEG STUDIES
    NIH R01MH045962Apr 1, 1990 - Mar 31, 1994
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Estimating multimodal brain variability in schizophrenia spectrum disorders: A worldwide ENIGMA study. bioRxiv. 2023 Nov 02. Omlor W, Rabe F, Fuchs S, Cecere G, Homan S, Surbeck W, Kallen N, Georgiadis F, Spiller T, Seifritz E, Weickert T, Bruggemann J, Weickert C, Potkin S, Hashimoto R, Sim K, Rootes-Murdy K, Quide Y, Houenou J, Banaj N, Vecchio D, Piras F, Piras F, Spalletta G, Salvador R, Karuk A, Pomarol-Clotet E, Rodrigue A, Pearlson G, Glahn D, Tomecek D, Spaniel F, Skoch A, Kirschner M, Kaiser S, Kochunov P, Fan FM, Andreassen OA, Westlye LT, Berthet P, Calhoun VD, Howells F, Uhlmann A, Scheffler F, Stein D, Iasevoli F, Cairns MJ, Carr VJ, Catts SV, Di Biase MA, Jablensky A, Green MJ, Henskens FA, Klauser P, Loughland C, Michie PT, Mowry B, Pantelis C, Rasser PE, Schall U, Scott R, Zalesky A, de Bartolomeis A, Barone A, Ciccarelli M, Brunetti A, Cocozza S, Pontillo G, Tranfa M, Di Giorgio A, Thomopoulos SI, Jahanshad N, Thompson PM, van Erp T, Turner J, Homan P. PMID: 37961617; PMCID: PMC10634976.
      View in: PubMed   Mentions:
    2. Identifying canonical and replicable multi-scale intrinsic connectivity networks in 100k+ resting-state fMRI datasets. Hum Brain Mapp. 2023 12 01; 44(17):5729-5748. Iraji A, Fu Z, Faghiri A, Duda M, Chen J, Rachakonda S, DeRamus T, Kochunov P, Adhikari BM, Belger A, Ford JM, Mathalon DH, Pearlson GD, Potkin SG, Preda A, Turner JA, van Erp TGM, Bustillo JR, Yang K, Ishizuka K, Faria A, Sawa A, Hutchison K, Osuch EA, Theberge J, Abbott C, Mueller BA, Zhi D, Zhuo C, Liu S, Xu Y, Salman M, Liu J, Du Y, Sui J, Adali T, Calhoun VD. PMID: 37787573; PMCID: PMC10619392.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses. Mol Psychiatry. 2023 Oct; 28(10):4363-4373. Banaj N, Vecchio D, Piras F, De Rossi P, Bustillo J, Ciufolini S, Dazzan P, Di Forti M, Dickie EW, Ford JM, Fuentes-Claramonte P, Gruber O, Guerrero-Pedraza A, Hamilton HK, Howells FM, Kraemer B, Lawrie SM, Mathalon DH, Murray R, Pomarol-Clotet E, Potkin SG, Preda A, Radua J, Richter A, Salvador R, Sawa A, Scheffler F, Sim K, Spaniel F, Stein DJ, Temmingh HS, Thomopoulos SI, Tomecek D, Uhlmann A, Voineskos A, Yang K, Jahanshad N, Thompson PM, Van Erp TGM, Turner JA, Spalletta G, Piras F. PMID: 37644174; PMCID: PMC10827665.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Auditory oddball hypoactivation in schizophrenia. Psychiatry Res Neuroimaging. 2023 10; 335:111710. Nakahara S, Male AG, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Voyvodic J, Belger A, Preda A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, Van Erp TGM. PMID: 37690161.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Alterations in grey matter structure linked to frequency-specific cortico-subcortical connectivity in schizophrenia via multimodal data fusion. bioRxiv. 2023 Jul 06. Duda M, Faghiri A, Belger A, Bustillo JR, Ford JM, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Sui J, Van Erp TGM, Calhoun VD. PMID: 37461731; PMCID: PMC10350020.
      View in: PubMed   Mentions:
    6. Multi-model order spatially constrained ICA reveals highly replicable group differences and consistent predictive results from resting data: A large N fMRI schizophrenia study. Neuroimage Clin. 2023; 38:103434. Meng X, Iraji A, Fu Z, Kochunov P, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson G, Potkin SG, Preda A, Turner J, van Erp TGM, Sui J, Calhoun VD. PMID: 37209635; PMCID: PMC10209454.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proc Natl Acad Sci U S A. 2023 04 04; 120(14):e2213880120. Schijven D, Postema MC, Fukunaga M, Matsumoto J, Miura K, de Zwarte SMC, van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS, Ayesa-Arriola R, Ortiz-García de la Foz V, Tordesillas-Gutierrez D, Vázquez-Bourgon J, Crespo-Facorro B, Alnæs D, Dahl A, Westlye LT, Agartz I, Andreassen OA, Jönsson EG, Kochunov P, Bruggemann JM, Catts SV, Michie PT, Mowry BJ, Quidé Y, Rasser PE, Schall U, Scott RJ, Carr VJ, Green MJ, Henskens FA, Loughland CM, Pantelis C, Weickert CS, Weickert TW, de Haan L, Brosch K, Pfarr JK, Ringwald KG, Stein F, Jansen A, Kircher TTJ, Nenadic I, Krämer B, Gruber O, Satterthwaite TD, Bustillo J, Mathalon DH, Preda A, Calhoun VD, Ford JM, Potkin SG, Chen J, Tan Y, Wang Z, Xiang H, Fan F, Bernardoni F, Ehrlich S, Fuentes-Claramonte P, Garcia-Leon MA, Guerrero-Pedraza A, Salvador R, Sarró S, Pomarol-Clotet E, Ciullo V, Piras F, Vecchio D, Banaj N, Spalletta G, Michielse S, van Amelsvoort T, Dickie EW, Voineskos AN, Sim K, Ciufolini S, Dazzan P, Murray RM, Kim WS, Chung YC, Andreou C, Schmidt A, Borgwardt S, McIntosh AM, Whalley HC, Lawrie SM, du Plessis S, Luckhoff HK, Scheffler F, Emsley R, Grotegerd D, Lencer R, Dannlowski U, Edmond JT, Rootes-Murdy K, Stephen JM, Mayer AR, Antonucci LA, Fazio L, Pergola G, Bertolino A, Díaz-Caneja CM, Janssen J, Lois NG, Arango C, Tomyshev AS, Lebedeva I, Cervenka S, Sellgren CM, Georgiadis F, Kirschner M, Kaiser S, Hajek T, Skoch A, Spaniel F, Kim M, Kwak YB, Oh S, Kwon JS, James A, Bakker G, Knöchel C, Stäblein M, Oertel V, Uhlmann A, Howells FM, Stein DJ, Temmingh HS, Diaz-Zuluaga AM, Pineda-Zapata JA, López-Jaramillo C, Homan S, Ji E, Surbeck W, Homan P, Fisher SE, Franke B, Glahn DC, Gur RC, Hashimoto R, Jahanshad N, Luders E, Medland SE, Thompson PM, Turner JA, van Erp TGM, Francks C. PMID: 36976765; PMCID: PMC10083554.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. Reliability and clinical utility of spatially constrained estimates of intrinsic functional networks from very short fMRI scans. Hum Brain Mapp. 2023 04 15; 44(6):2620-2635. Duda M, Iraji A, Ford JM, Lim KO, Mathalon DH, Mueller BA, Potkin SG, Preda A, Van Erp TGM, Calhoun VD. PMID: 36840728; PMCID: PMC10028646.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia. Psychiatry Res Neuroimaging. 2023 03; 329:111597. Cheon EJ, Male AG, Gao B, Adhikari BM, Edmond JT, Hare SM, Belger A, Potkin SG, Bustillo JR, Mathalon DH, Ford JM, Lim KO, Mueller BA, Preda A, O'Leary D, Strauss GP, Ahmed AO, Thompson PM, Jahanshad N, Kochunov P, Calhoun VD, Turner JA, van Erp TGM. PMID: 36680843.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. A method for estimating and characterizing explicitly nonlinear dynamic functional network connectivity in resting-state fMRI data. J Neurosci Methods. 2023 04 01; 389:109794. Motlaghian SM, Vahidi V, Belger A, Bustillo JR, Faghiri A, Ford JM, Iraji A, Lim K, Mathalon DH, Miller R, Mueller BA, O'Leary D, Potkin SG, Preda A, van Erp TG, Calhoun VD. PMID: 36652974.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Genome-Transcriptome-Functional Connectivity-Cognition Link Differentiates Schizophrenia From Bipolar Disorder. Schizophr Bull. 2022 11 18; 48(6):1306-1317. Chen J, Fu Z, Bustillo JR, Perrone-Bizzozero NI, Lin D, Canive J, Pearlson GD, Stephen JM, Mayer AR, Potkin SG, van Erp TGM, Kochunov P, Elliot Hong L, Adhikari BM, Andreassen OA, Agartz I, Westlye LT, Sui J, Du Y, Macciardi F, Hanlon FM, Jung RE, Turner JA, Liu J, Calhoun VD. PMID: 35988022; PMCID: PMC9673262.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    12. Nonlinear functional network connectivity in resting functional magnetic resonance imaging data. Hum Brain Mapp. 2022 10 15; 43(15):4556-4566. Motlaghian SM, Belger A, Bustillo JR, Ford JM, Iraji A, Lim K, Mathalon DH, Mueller BA, O'Leary D, Pearlson G, Potkin SG, Preda A, van Erp TGM, Calhoun VD. PMID: 35762454; PMCID: PMC9491296.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Multi-spatial-scale dynamic interactions between functional sources reveal sex-specific changes in schizophrenia. Netw Neurosci. 2022 Jun; 6(2):357-381. Iraji A, Faghiri A, Fu Z, Rachakonda S, Kochunov P, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, van Erp TGM, Calhoun VD. PMID: 35733435; PMCID: PMC9208002.
      View in: PubMed   Mentions: 13  
    14. Moving beyond the 'CAP' of the Iceberg: Intrinsic connectivity networks in fMRI are continuously engaging and overlapping. Neuroimage. 2022 05 01; 251:119013. Iraji A, Faghiri A, Fu Z, Kochunov P, Adhikari BM, Belger A, Ford JM, McEwen S, Mathalon DH, Pearlson GD, Potkin SG, Preda A, Turner JA, Van Erp TGM, Chang C, Calhoun VD. PMID: 35189361; PMCID: PMC9107614.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Multimodel Order Independent Component Analysis: A Data-Driven Method for Evaluating Brain Functional Network Connectivity Within and Between Multiple Spatial Scales. Brain Connect. 2022 09; 12(7):617-628. Meng X, Iraji A, Fu Z, Kochunov P, Belger A, Ford J, McEwen S, Mathalon DH, Mueller BA, Pearlson G, Potkin SG, Preda A, Turner J, Erp TV, Sui J, Calhoun VD. PMID: 34541879; PMCID: PMC9529308.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. Hum Brain Mapp. 2022 01; 43(1):352-372. Gutman BA, van Erp TGM, Alpert K, Ching CRK, Isaev D, Ragothaman A, Jahanshad N, Saremi A, Zavaliangos-Petropulu A, Glahn DC, Shen L, Cong S, Alnaes D, Andreassen OA, Doan NT, Westlye LT, Kochunov P, Satterthwaite TD, Wolf DH, Huang AJ, Kessler C, Weideman A, Nguyen D, Mueller BA, Faziola L, Potkin SG, Preda A, Mathalon DH, Bustillo J, Calhoun V, Ford JM, Walton E, Ehrlich S, Ducci G, Banaj N, Piras F, Piras F, Spalletta G, Canales-Rodríguez EJ, Fuentes-Claramonte P, Pomarol-Clotet E, Radua J, Salvador R, Sarró S, Dickie EW, Voineskos A, Tordesillas-Gutiérrez D, Crespo-Facorro B, Setién-Suero E, van Son JM, Borgwardt S, Schönborn-Harrisberger F, Morris D, Donohoe G, Holleran L, Cannon D, McDonald C, Corvin A, Gill M, Filho GB, Rosa PGP, Serpa MH, Zanetti MV, Lebedeva I, Kaleda V, Tomyshev A, Crow T, James A, Cervenka S, Sellgren CM, Fatouros-Bergman H, Agartz I, Howells F, Stein DJ, Temmingh H, Uhlmann A, de Zubicaray GI, McMahon KL, Wright M, Cobia D, Csernansky JG, Thompson PM, Turner JA, Wang L. PMID: 34498337; PMCID: PMC8675416.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    17. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. Hum Brain Mapp. 2022 01; 43(1):431-451. Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur-Streubel R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Buckner RL, Calhoun V, Canales-Rodríguez EJ, Cannon DM, Caseras X, Castellanos FX, Cervenka S, Chaim-Avancini TM, Ching CRK, Chubar V, Clark VP, Conrod P, Conzelmann A, Crespo-Facorro B, Crivello F, Crone EA, Dale AM, Dannlowski U, Davey C, de Geus EJC, de Haan L, de Zubicaray GI, den Braber A, Dickie EW, Di Giorgio A, Doan NT, Dørum ES, Ehrlich S, Erk S, Espeseth T, Fatouros-Bergman H, Fisher SE, Fouche JP, Franke B, Frodl T, Fuentes-Claramonte P, Glahn DC, Gotlib IH, Grabe HJ, Grimm O, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Gur RE, Gur RC, Hahn T, Harrison BJ, Hartman CA, Hatton SN, Heinz A, Heslenfeld DJ, Hibar DP, Hickie IB, Ho BC, Hoekstra PJ, Hohmann S, Holmes AJ, Hoogman M, Hosten N, Howells FM, Hulshoff Pol HE, Huyser C, Jahanshad N, James A, Jernigan TL, Jiang J, Jönsson EG, Joska JA, Kahn R, Kalnin A, Kanai R, Klein M, Klyushnik TP, Koenders L, Koops S, Krämer B, Kuntsi J, Lagopoulos J, Lázaro L, Lebedeva I, Lee WH, Lesch KP, Lochner C, Machielsen MWJ, Maingault S, Martin NG, Martínez-Zalacaín I, Mataix-Cols D, Mazoyer B, McDonald C, McDonald BC, McIntosh AM, McMahon KL, McPhilemy G, Meinert S, Menchón JM, Medland SE, Meyer-Lindenberg A, Naaijen J, Najt P, Nakao T, Nordvik JE, Nyberg L, Oosterlaan J, de la Foz VO, Paloyelis Y, Pauli P, Pergola G, Pomarol-Clotet E, Portella MJ, Potkin SG, Radua J, Reif A, Rinker DA, Roffman JL, Rosa PGP, Sacchet MD, Sachdev PS, Salvador R, Sánchez-Juan P, Sarró S, Satterthwaite TD, Saykin AJ, Serpa MH, Schmaal L, Schnell K, Schumann G, Sim K, Smoller JW, Sommer I, Soriano-Mas C, Stein DJ, Strike LT, Swagerman SC, Tamnes CK, Temmingh HS, Thomopoulos SI, Tomyshev AS, Tordesillas-Gutiérrez D, Trollor JN, Turner JA, Uhlmann A, van den Heuvel OA, van den Meer D, van der Wee NJA, van Haren NEM, van 't Ent D, van Erp TGM, Veer IM, Veltman DJ, Voineskos A, Völzke H, Walter H, Walton E, Wang L, Wang Y, Wassink TH, Weber B, Wen W, West JD, Westlye LT, Whalley H, Wierenga LM, Wittfeld K, Wolf DH, Worker A, Wright MJ, Yang K, Yoncheva Y, Zanetti MV, Ziegler GC, Karolinska Schizophrenia Project (KaSP), Thompson PM, Dima D. PMID: 33595143; PMCID: PMC8675431.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    18. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. Hum Brain Mapp. 2022 01; 43(1):452-469. Dima D, Modabbernia A, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, Bargallo N, Baumeister S, Baur-Streubel R, Bertolino A, Bonvino A, Boomsma DI, Borgwardt S, Bourque J, Brandeis D, Breier A, Brodaty H, Brouwer RM, Buitelaar JK, Busatto GF, Buckner RL, Calhoun V, Canales-Rodríguez EJ, Cannon DM, Caseras X, Castellanos FX, Cervenka S, Chaim-Avancini TM, Ching CRK, Chubar V, Clark VP, Conrod P, Conzelmann A, Crespo-Facorro B, Crivello F, Crone EA, Dannlowski U, Dale AM, Davey C, de Geus EJC, de Haan L, de Zubicaray GI, den Braber A, Dickie EW, Di Giorgio A, Doan NT, Dørum ES, Ehrlich S, Erk S, Espeseth T, Fatouros-Bergman H, Fisher SE, Fouche JP, Franke B, Frodl T, Fuentes-Claramonte P, Glahn DC, Gotlib IH, Grabe HJ, Grimm O, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Gur RE, Gur RC, Hahn T, Harrison BJ, Hartman CA, Hatton SN, Heinz A, Heslenfeld DJ, Hibar DP, Hickie IB, Ho BC, Hoekstra PJ, Hohmann S, Holmes AJ, Hoogman M, Hosten N, Howells FM, Hulshoff Pol HE, Huyser C, Jahanshad N, James A, Jernigan TL, Jiang J, Jönsson EG, Joska JA, Kahn R, Kalnin A, Kanai R, Klein M, Klyushnik TP, Koenders L, Koops S, Krämer B, Kuntsi J, Lagopoulos J, Lázaro L, Lebedeva I, Lee WH, Lesch KP, Lochner C, Machielsen MWJ, Maingault S, Martin NG, Martínez-Zalacaín I, Mataix-Cols D, Mazoyer B, McDonald C, McDonald BC, McIntosh AM, McMahon KL, McPhilemy G, Meinert S, Menchón JM, Medland SE, Meyer-Lindenberg A, Naaijen J, Najt P, Nakao T, Nordvik JE, Nyberg L, Oosterlaan J, de la Foz VO, Paloyelis Y, Pauli P, Pergola G, Pomarol-Clotet E, Portella MJ, Potkin SG, Radua J, Reif A, Rinker DA, Roffman JL, Rosa PGP, Sacchet MD, Sachdev PS, Salvador R, Sánchez-Juan P, Sarró S, Satterthwaite TD, Saykin AJ, Serpa MH, Schmaal L, Schnell K, Schumann G, Sim K, Smoller JW, Sommer I, Soriano-Mas C, Stein DJ, Strike LT, Swagerman SC, Tamnes CK, Temmingh HS, Thomopoulos SI, Tomyshev AS, Tordesillas-Gutiérrez D, Trollor JN, Turner JA, Uhlmann A, van den Heuvel OA, van den Meer D, van der Wee NJA, van Haren NEM, Van't Ent D, van Erp TGM, Veer IM, Veltman DJ, Voineskos A, Völzke H, Walter H, Walton E, Wang L, Wang Y, Wassink TH, Weber B, Wen W, West JD, Westlye LT, Whalley H, Wierenga LM, Williams SCR, Wittfeld K, Wolf DH, Worker A, Wright MJ, Yang K, Yoncheva Y, Zanetti MV, Ziegler GC, Thompson PM, Frangou S, Karolinska Schizophrenia Project (KaSP). PMID: 33570244; PMCID: PMC8675429.
      View in: PubMed   Mentions: 46     Fields:    
    19. Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. Biol Psychiatry. 2021 10 15; 90(8):529-539. Qi S, Schumann G, Bustillo J, Turner JA, Jiang R, Zhi D, Fu Z, Mayer AR, Vergara VM, Silva RF, Iraji A, Chen J, Damaraju E, Ma X, Yang X, Stevens M, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, Potkin SG, Preda A, Zhuo C, Xu Y, Chu C, Banaschewski T, Barker GJ, Bokde ALW, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Fröhner JH, Smolka MN, Walter H, Whelan R, Calhoun VD, Sui J, IMAGEN Consortium. PMID: 33875230; PMCID: PMC8322149.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Brain amyloid and the transition to dementia in Down syndrome. Alzheimers Dement (Amst). 2020; 12(1):e12126. Keator DB, Doran E, Taylor L, Phelan MJ, Hom C, Tseung K, van Erp TGM, Potkin SG, Brickman AM, Rosas DH, Yassa MA, Silverman W, Lott IT. PMID: 33204814; PMCID: PMC7656170.
      View in: PubMed   Mentions: 5  
    21. The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research. Focus (Am Psychiatr Publ). 2020 Oct; 18(4):456-465. Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, Olfson M, Howes OD. PMID: 33343259; PMCID: PMC7725153.
      View in: PubMed   Mentions: 5  
    22. Liver enzyme CYP2D6 gene and tardive dyskinesia. Pharmacogenomics. 2020 10; 21(15):1065-1072. Lu JY, Tiwari AK, Freeman N, Zai GC, Luca V, Müller DJ, Tampakeras M, Herbert D, Emmerson H, Cheema SY, King N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL, Zai CC. PMID: 32969762; PMCID: PMC7586356.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia. Drug Dev Res. 2021 08; 82(5):678-684. Maes MS, Lu JY, Tiwari AK, Freeman N, de Luca V, Müller DJ, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL, Zai CC. PMID: 32394511.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study. Psychiatry Res Neuroimaging. 2020 07 30; 301:111085. van Erp TG, Baker RA, Cox K, Okame T, Kojima Y, Eramo A, Potkin SG. PMID: 32450497.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium. Am J Psychiatry. 2020 06 01; 177(6):537-547. Holleran L, Kelly S, Alloza C, Agartz I, Andreassen OA, Arango C, Banaj N, Calhoun V, Cannon D, Carr V, Corvin A, Glahn DC, Gur R, Hong E, Hoschl C, Howells FM, James A, Janssen J, Kochunov P, Lawrie SM, Liu J, Martinez C, McDonald C, Morris D, Mothersill D, Pantelis C, Piras F, Potkin S, Rasser PE, Roalf D, Rowland L, Satterthwaite T, Schall U, Spalletta G, Spaniel F, Stein DJ, Uhlmann A, Voineskos A, Zalesky A, van Erp TGM, Turner JA, Deary IJ, Thompson PM, Jahanshad N, Donohoe G. PMID: 32212855; PMCID: PMC7938666.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    26. Covarying structural alterations in laterality of the temporal lobe in schizophrenia: A case for source-based laterality. NMR Biomed. 2020 06; 33(6):e4294. DeRamus TP, Silva RF, Iraji A, Damaraju E, Belger A, Ford JM, McEwen SC, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 32207187; PMCID: PMC8311554.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study. J Clin Psychiatry. 2020 03 03; 81(2). Potkin SG, Kunovac J, Silverman BL, Simmons A, Jiang Y, DiPetrillo L, McDonnell D. PMID: 32141723.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    28. Meta-Modal Information Flow: A Method for Capturing Multimodal Modular Disconnectivity in Schizophrenia. IEEE Trans Biomed Eng. 2020 09; 67(9):2572-2584. Falakshahi H, Vergara VM, Liu J, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Rokham H, Sui J, Turner JA, Plis S, Calhoun VD. PMID: 31944934; PMCID: PMC7538162.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020 Jan 07; 6(1):1. Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, Olfson M, Howes OD. PMID: 31911624; PMCID: PMC6946650.
      View in: PubMed   Mentions: 89  
    30. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 11; 51(11):1624-1636. Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, Teumer A, van der Lee SJ, Yang J, Yanek LR, Lee TV, Li S, Hu Y, Koh JY, Eicher JD, Desrivières S, Arias-Vasquez A, Chauhan G, Athanasiu L, Rentería ME, Kim S, Hoehn D, Armstrong NJ, Chen Q, Holmes AJ, den Braber A, Kloszewska I, Andersson M, Espeseth T, Grimm O, Abramovic L, Alhusaini S, Milaneschi Y, Papmeyer M, Axelsson T, Ehrlich S, Roiz-Santiañez R, Kraemer B, Håberg AK, Jones HJ, Pike GB, Stein DJ, Stevens A, Bralten J, Vernooij MW, Harris TB, Filippi I, Witte AV, Guadalupe T, Wittfeld K, Mosley TH, Becker JT, Doan NT, Hagenaars SP, Saba Y, Cuellar-Partida G, Amin N, Hilal S, Nho K, Mirza-Schreiber N, Arfanakis K, Becker DM, Ames D, Goldman AL, Lee PH, Boomsma DI, Lovestone S, Giddaluru S, Le Hellard S, Mattheisen M, Bohlken MM, Kasperaviciute D, Schmaal L, Lawrie SM, Agartz I, Walton E, Tordesillas-Gutierrez D, Davies GE, Shin J, Ipser JC, Vinke LN, Hoogman M, Jia T, Burkhardt R, Klein M, Crivello F, Janowitz D, Carmichael O, Haukvik UK, Aribisala BS, Schmidt H, Strike LT, Cheng CY, Risacher SL, Pütz B, Fleischman DA, Assareh AA, Mattay VS, Buckner RL, Mecocci P, Dale AM, Cichon S, Boks MP, Matarin M, Penninx BWJH, Calhoun VD, Chakravarty MM, Marquand AF, Macare C, Kharabian Masouleh S, Oosterlaan J, Amouyel P, Hegenscheid K, Rotter JI, Schork AJ, Liewald DCM, de Zubicaray GI, Wong TY, Shen L, Sämann PG, Brodaty H, Roffman JL, de Geus EJC, Tsolaki M, Erk S, van Eijk KR, Cavalleri GL, van der Wee NJA, McIntosh AM, Gollub RL, Bulayeva KB, Bernard M, Richards JS, Himali JJ, Loeffler M, Rommelse N, Hoffmann W, Westlye LT, Valdés Hernández MC, Hansell NK, van Erp TGM, Wolf C, Kwok JBJ, Vellas B, Heinz A, Olde Loohuis LM, Delanty N, Ho BC, Ching CRK, Shumskaya E, Singh B, Hofman A, van der Meer D, Homuth G, Psaty BM, Bastin ME, Montgomery GW, Foroud TM, Reppermund S, Hottenga JJ, Simmons A, Meyer-Lindenberg A, Cahn W, Whelan CD, van Donkelaar MMJ, Yang Q, Hosten N, Green RC, Thalamuthu A, Mohnke S, Hulshoff Pol HE, Lin H, Jack CR, Schofield PR, Mühleisen TW, Maillard P, Potkin SG, Wen W, Fletcher E, Toga AW, Gruber O, Huentelman M, Davey Smith G, Launer LJ, Nyberg L, Jönsson EG, Crespo-Facorro B, Koen N, Greve DN, Uitterlinden AG, Weinberger DR, Steen VM, Fedko IO, Groenewold NA, Niessen WJ, Toro R, Tzourio C, Longstreth WT, Ikram MK, Smoller JW, van Tol MJ, Sussmann JE, Paus T, Lemaître H, Schroeter ML, Mazoyer B, Andreassen OA, Holsboer F, Depondt C, Veltman DJ, Turner JA, Pausova Z, Schumann G, van Rooij D, Djurovic S, Deary IJ, McMahon KL, Müller-Myhsok B, Brouwer RM, Soininen H, Pandolfo M, Wassink TH, Cheung JW, Wolfers T, Martinot JL, Zwiers MP, Nauck M, Melle I, Martin NG, Kanai R, Westman E, Kahn RS, Sisodiya SM, White T, Saremi A, van Bokhoven H, Brunner HG, Völzke H, Wright MJ, van 't Ent D, Nöthen MM, Ophoff RA, Buitelaar JK, Fernández G, Sachdev PS, Rietschel M, van Haren NEM, Fisher SE, Beiser AS, Francks C, Saykin AJ, Mather KA, Romanczuk-Seiferth N, Hartman CA, DeStefano AL, Heslenfeld DJ, Weiner MW, Walter H, Hoekstra PJ, Nyquist PA, Franke B, Bennett DA, Grabe HJ, Johnson AD, Chen C, van Duijn CM, Lopez OL, Fornage M, Wardlaw JM, Schmidt R, DeCarli C, De Jager PL, Villringer A, Debette S, Gudnason V, Medland SE, Shulman JM, Thompson PM, Seshadri S, Ikram MA. PMID: 31636452; PMCID: PMC7055269.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimals
    31. Altered Domain Functional Network Connectivity Strength and Randomness in Schizophrenia. Front Psychiatry. 2019; 10:499. Vergara VM, Damaraju E, Turner JA, Pearlson G, Belger A, Mathalon DH, Potkin SG, Preda A, Vaidya JG, van Erp TGM, McEwen S, Calhoun VD. PMID: 31396111; PMCID: PMC6664085.
      View in: PubMed   Mentions: 3  
    32. Characterizing Whole Brain Temporal Variation of Functional Connectivity via Zero and First Order Derivatives of Sliding Window Correlations. Front Neurosci. 2019; 13:634. Espinoza FA, Vergara VM, Damaraju E, Henke KG, Faghiri A, Turner JA, Belger AA, Ford JM, McEwen SC, Mathalon DH, Mueller BA, Potkin SG, Preda A, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 31316333; PMCID: PMC6611425.
      View in: PubMed   Mentions: 7  
    33. Salience-Default Mode Functional Network Connectivity Linked to Positive and Negative Symptoms of Schizophrenia. Schizophr Bull. 2019 06 18; 45(4):892-901. Hare SM, Ford JM, Mathalon DH, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA. PMID: 30169884; PMCID: PMC6581131.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    34. Dentate gyrus volume deficit in schizophrenia. Psychol Med. 2020 06; 50(8):1267-1277. Nakahara S, Turner JA, Calhoun VD, Lim KO, Mueller B, Bustillo JR, O'Leary DS, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Macciardi F, Matsumoto M, Potkin SG, van Erp TGM. PMID: 31155012; PMCID: PMC7068799.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. Parallel group ICA+ICA: Joint estimation of linked functional network variability and structural covariation with application to schizophrenia. Hum Brain Mapp. 2019 09; 40(13):3795-3809. Qi S, Sui J, Chen J, Liu J, Jiang R, Silva R, Iraji A, Damaraju E, Salman M, Lin D, Fu Z, Zhi D, Turner JA, Bustillo J, Ford JM, Mathalon DH, Voyvodic J, McEwen S, Preda A, Belger A, Potkin SG, Mueller BA, Adali T, Calhoun VD. PMID: 31099151; PMCID: PMC6865807.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Autoconnectivity: A new perspective on human brain function. J Neurosci Methods. 2019 07 15; 323:68-76. Arbabshirani MR, Preda A, Vaidya JG, Potkin SG, Pearlson G, Voyvodic J, Mathalon D, van Erp T, Michael A, Kiehl KA, Turner JA, Calhoun VD. PMID: 31005575.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. N-BiC: A Method for Multi-Component and Symptom Biclustering of Structural MRI Data: Application to Schizophrenia. IEEE Trans Biomed Eng. 2020 01; 67(1):110-121. Rahaman MA, Turner JA, Gupta CN, Rachakonda S, Chen J, Liu J, van Erp TGM, Potkin S, Ford J, Mathalon D, Lee HJ, Jiang W, Mueller BA, Andreassen O, Agartz I, Sponheim SR, Mayer AR, Stephen J, Jung RE, Canive J, Bustillo J, Calhoun VD. PMID: 30946659; PMCID: PMC7906485.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    38. The spatial chronnectome reveals a dynamic interplay between functional segregation and integration. Hum Brain Mapp. 2019 07; 40(10):3058-3077. Iraji A, Deramus TP, Lewis N, Yaesoubi M, Stephen JM, Erhardt E, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 30884018; PMCID: PMC6548674.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    39. Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia. J Clin Psychiatry. 2019 03 05; 80(2). Kane JM, Agid O, Baldwin ML, Howes O, Lindenmayer JP, Marder S, Olfson M, Potkin SG, Correll CU. PMID: 30840788.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    40. Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study. Schizophr Res. 2019 06; 208:44-48. Miller BJ, Claxton A, Du Y, Weiden PJ, Potkin SG. PMID: 30745067.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    41. Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial. J Clin Psychiatry. 2019 01 08; 80(2). Correll CU, Potkin SG, Zhong Y, Harsányi J, Szatmári B, Earley W. PMID: 30695290.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    42. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophr Bull. 2019 01 01; 45(1):222-232. Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, Hanlon FM, Jung RE, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Tamminga CA, Andreassen OA, Agartz I, Westlye LT, Sui J, Du Y, Turner JA, Liu J. PMID: 29474680; PMCID: PMC6293216.
      View in: PubMed   Mentions: 22     Fields:    
    43. Spatial dynamics within and between brain functional domains: A hierarchical approach to study time-varying brain function. Hum Brain Mapp. 2019 04 15; 40(6):1969-1986. Iraji A, Fu Z, Damaraju E, DeRamus TP, Lewis N, Bustillo JR, Lenroot RK, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 30588687; PMCID: PMC6692083.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process? Biol Psychiatry. 2019 04 01; 85(7):e35-e39. van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Clark VP, Mueller BA, de Zwarte SMC, Ophoff RA, van Haren NEM, Andreassen OA, Gurholt TP, Gruber O, Kraemer B, Richter A, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Catts S, Fullerton JM, Green MJ, Henskens F, Jablensky A, Mowry BJ, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Hong E, Kochunov P, Gur RE, Gur RC, Ford JM, Macciardi F, Mathalon DH, Potkin SG, Preda A, Fan F, Ehrlich S, King MD, De Haan L, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, Pomarol-Clotet E, Kelly S, Ciufolini S, Radua J, Murray R, Marques TR, Simmons A, Borgwardt S, Schönborn-Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Yun JY, Cannon DM, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L, Karolinska Schizophrenia Project, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, McIntosh AM, Whalley HC, Knöchel C, Oertel-Knöchel V, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA. PMID: 30470561; PMCID: PMC7041557.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. A framework for linking resting-state chronnectome/genome features in schizophrenia: A pilot study. Neuroimage. 2019 01 01; 184:843-854. Rashid B, Chen J, Rashid I, Damaraju E, Liu J, Miller R, Agcaoglu O, van Erp TGM, Lim KO, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Bustillo JR, Pearlson GD, Calhoun VD. PMID: 30300752; PMCID: PMC6230505.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-Analysis. Front Pharmacol. 2018; 9:974. Zai CC, Lee FH, Tiwari AK, Lu JY, de Luca V, Maes MS, Herbert D, Shahmirian A, Cheema SY, Zai GC, Atukuri A, Sherman M, Shaikh SA, Tampakeras M, Freeman N, King N, Müller DJ, Greenbaum L, Lerer B, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL. PMID: 30283332; PMCID: PMC6157325.
      View in: PubMed   Mentions: 9  
    47. Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia. Neurosci Lett. 2018 11 01; 686:17-22. Lu JY, Tiwari AK, Zai GC, Rastogi A, Shaikh SA, Müller DJ, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Wong AHC, Kennedy JL, Zai CC. PMID: 30118782.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion. Nat Commun. 2018 08 02; 9(1):3028. Sui J, Qi S, van Erp TGM, Bustillo J, Jiang R, Lin D, Turner JA, Damaraju E, Mayer AR, Cui Y, Fu Z, Du Y, Chen J, Potkin SG, Preda A, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen SC, O'Leary DS, McMahon A, Jiang T, Calhoun VD. PMID: 30072715; PMCID: PMC6072778.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    49. A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS. Schizophr Res. 2018 11; 201:113-119. Preda A, Nguyen DD, Bustillo JR, Belger A, O'Leary DS, McEwen S, Ling S, Faziola L, Mathalon DH, Ford JM, Potkin SG, FBIRN, van Erp TGM. PMID: 29935887; PMCID: PMC7039318.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. Schizophr Res. 2018 11; 201:393-399. Nakahara S, Medland S, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Vaidya JG, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, van Erp TGM. PMID: 29907492; PMCID: PMC6252137.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Decreased hemispheric connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional network connectivity in schizophrenia. Brain Imaging Behav. 2018 Jun; 12(3):615-630. Agcaoglu O, Miller R, Damaraju E, Rashid B, Bustillo J, Cetin MS, Van Erp TGM, McEwen S, Preda A, Ford JM, Lim KO, Manoach DS, Mathalon DH, Potkin SG, Calhoun VD. PMID: 28434159; PMCID: PMC5651208.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. New directions in therapeutics for Huntington disease. Future Neurol. 2018 May; 13(2):101-121. Potkin KT, Potkin SG. PMID: 30800004; PMCID: PMC6378950.
      View in: PubMed   Mentions: 15  
    53. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies. Alzheimers Dement. 2018 09; 14(9):1137-1147. Saeed U, Mirza SS, MacIntosh BJ, Herrmann N, Keith J, Ramirez J, Nestor SM, Yu Q, Knight J, Swardfager W, Potkin SG, Rogaeva E, St George-Hyslop P, Black SE, Masellis M. PMID: 29782824.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    54. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018 11 01; 84(9):644-654. van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L, Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA. PMID: 29960671; PMCID: PMC6177304.
      View in: PubMed   Mentions: 301     Fields:    Translation:Humans
    55. Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia. Schizophr Res. 2018 09; 199:226-234. Hare SM, Law AS, Ford JM, Mathalon DH, Ahmadi A, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA. PMID: 29571753; PMCID: PMC6148405.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms. Psychol Med. 2018 11; 48(15):2492-2499. Ferri J, Ford JM, Roach BJ, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya JG, Potkin SG, Mathalon DH. PMID: 29444726.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    57. Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence. Mol Neuropsychiatry. 2018 Feb; 3(3):157-169. Rollins BL, Morgan L, Hjelm BE, Sequeira A, Schatzberg AF, Barchas JD, Lee FS, Myers RM, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP. PMID: 29594135; PMCID: PMC5836256.
      View in: PubMed   Mentions: 21  
    58. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2018 05; 23(5):1261-1269. Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G. PMID: 29038599; PMCID: PMC5984078.
      View in: PubMed   Mentions: 277     Fields:    Translation:Humans
    59. Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia. Front Psychiatry. 2017; 8:179. Gupta CN, Castro E, Rachkonda S, van Erp TGM, Potkin S, Ford JM, Mathalon D, Lee HJ, Mueller BA, Greve DN, Andreassen OA, Agartz I, Mayer AR, Stephen J, Jung RE, Bustillo J, Calhoun VD, Turner JA. PMID: 29018368; PMCID: PMC5623192.
      View in: PubMed   Mentions: 13  
    60. Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging. Mach Learn Med Imaging. 2017 Sep; 10541:371-378. Petrov D, Gutman BA, Yu SJ, van Erp TGM, Turner JA, Schmaal L, Veltman D, Wang L, Alpert K, Isaev D, Zavaliangos-Petropulu A, Ching CRK, Calhoun V, Glahn D, Satterthwaite TD, Andreasen OA, Borgwardt S, Howells F, Groenewold N, Voineskos A, Radua J, Potkin SG, Crespo-Facorro B, Tordesillas-Gutiérrez D, Shen L, Lebedeva I, Spalletta G, Donohoe G, Kochunov P, Rosa PGP, James A, Dannlowski U, Baune BT, Aleman A, Gotlib IH, Walter H, Walter M, Soares JC, Ehrlich S, Gur RC, Doan NT, Agartz I, Westlye LT, Harrisberger F, Riecher-Rössler A, Uhlmann A, Stein DJ, Dickie EW, Pomarol-Clotet E, Fuentes-Claramonte P, Canales-Rodríguez EJ, Salvador R, Huang AJ, Roiz-Santiañez R, Cong S, Tomyshev A, Piras F, Vecchio D, Banaj N, Ciullo V, Hong E, Busatto G, Zanetti MV, Serpa MH, Cervenka S, Kelly S, Grotegerd D, Sacchet MD, Veer IM, Li M, Wu MJ, Irungu B, Walton E, Thompson PM. PMID: 30035274; PMCID: PMC6049825.
      View in: PubMed   Mentions: 3  
    61. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study. PLoS One. 2017; 12(8):e0183475. Potkin SG, Loze JY, Forray C, Baker RA, Sapin C, Peters-Strickland T, Beillat M, Nylander AG, Hertel P, Nitschky Schmidt S, Ettrup A, Eramo A, Hansen K, Naber D. PMID: 28837593; PMCID: PMC5570322.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    62. Multimodal Fusion With Reference: Searching for Joint Neuromarkers of Working Memory Deficits in Schizophrenia. IEEE Trans Med Imaging. 2018 01; 37(1):93-105. Qi S, Calhoun VD, van Erp TGM, Bustillo J, Damaraju E, Turner JA, Du Y, Yang J, Chen J, Yu Q, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Jiang T, Sui J. PMID: 28708547; PMCID: PMC5750081.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    63. Maternal Systemic Interleukin-6 During Pregnancy Is Associated With Newborn Amygdala Phenotypes and Subsequent Behavior at 2 Years of Age. Biol Psychiatry. 2018 Jan 15; 83(2):109-119. Graham AM, Rasmussen JM, Rudolph MD, Heim CM, Gilmore JH, Styner M, Potkin SG, Entringer S, Wadhwa PD, Fair DA, Buss C. PMID: 28754515; PMCID: PMC5723539.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    64. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol Med. 2018 Jan; 48(1):82-94. Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Morch-Johnsen L, Færden A, Flyckt L, Fatouros-Bergman H, Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG, Hashimoto R, Yamamori H, Fukunaga M, Jahanshad N, De Rossi P, Piras F, Banaj N, Spalletta G, Gur RE, Gur RC, Wolf DH, Satterthwaite TD, Beard LM, Sommer IE, Koops S, Gruber O, Richter A, Krämer B, Kelly S, Donohoe G, McDonald C, Cannon DM, Corvin A, Gill M, Di Giorgio A, Bertolino A, Lawrie S, Nickson T, Whalley HC, Neilson E, Calhoun VD, Thompson PM, Turner JA, Ehrlich S. PMID: 28545597; PMCID: PMC5826665.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    65. Newborn insula gray matter volume is prospectively associated with early life adiposity gain. Int J Obes (Lond). 2017 09; 41(9):1434-1439. Rasmussen JM, Entringer S, Kruggel F, Cooper DM, Styner M, Gilmore JH, Potkin SG, Wadhwa PD, Buss C. PMID: 28487552; PMCID: PMC5585030.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    66. Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY. Int Clin Psychopharmacol. 2017 05; 32(3):147-154. Potkin SG, Loze JY, Forray C, Baker RA, Sapin C, Peters-Strickland T, Beillat M, Nylander AG, Hertel P, Steen Andersen H, Eramo A, Hansen K, Naber D. PMID: 28252452; PMCID: PMC5378005.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    67. Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study. Schizophr Res. 2018 02; 192:205-210. Naber D, Baker RA, Eramo A, Forray C, Hansen K, Sapin C, Peters-Strickland T, Nylander AG, Hertel P, Nitschky Schmidt S, Loze JY, Potkin SG. PMID: 28433498.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia. World J Biol Psychiatry. 2019 01; 20(1):91-95. Zai CC, Tiwari AK, Chowdhury NI, Yilmaz Z, de Luca V, Müller DJ, Potkin SG, Lieberman JA, Meltzer HY, Voineskos AN, Remington G, Kennedy JL. PMID: 28394697.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    69. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatr Scand. 2017 May; 135(5):439-447. Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, Andreassen OA, Westlye LT, Melle I, Berg AO, Mørch-Johnsen L, Faerden A, Flyckt L, Fatouros-Bergman H, Karolinska Schizophrenia Project Consortium (KaSP), Jönsson EG, Hashimoto R, Yamamori H, Fukunaga M, Preda A, De Rossi P, Piras F, Banaj N, Ciullo V, Spalletta G, Gur RE, Gur RC, Wolf DH, Satterthwaite TD, Beard LM, Sommer IE, Koops S, Gruber O, Richter A, Krämer B, Kelly S, Donohoe G, McDonald C, Cannon DM, Corvin A, Gill M, Di Giorgio A, Bertolino A, Lawrie S, Nickson T, Whalley HC, Neilson E, Calhoun VD, Thompson PM, Turner JA, Ehrlich S. PMID: 28369804; PMCID: PMC5399182.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    70. Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation. Schizophr Res. 2017 12; 190:115-120. Potkin SG, Risinger R, Du Y, Zummo J, Bose A, Silverman B, Stankovic S, Ehrich E. PMID: 28342578.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia. Schizophr Bull. 2017 03 01; 43(2):389-396. Hare SM, Ford JM, Ahmadi A, Damaraju E, Belger A, Bustillo J, Lee HJ, Mathalon DH, Mueller BA, Preda A, van Erp TG, Potkin SG, Calhoun VD, Turner JA, Functional Imaging Biomedical Informatics Research Network. PMID: 27421792; PMCID: PMC5605256.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    72. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 01 18; 8:13624. Hibar DP, Adams HHH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beecham AH, Beiser A, Bernard M, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chen Q, Ching CRK, Chouraki V, Cuellar-Partida G, Crivello F, Den Braber A, Doan NT, Ehrlich S, Giddaluru S, Goldman AL, Gottesman RF, Grimm O, Griswold ME, Guadalupe T, Gutman BA, Hass J, Haukvik UK, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Jørgensen KN, Karbalai N, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liewald DCM, Lopez LM, Luciano M, Macare C, Marquand AF, Matarin M, Mather KA, Mattheisen M, McKay DR, Milaneschi Y, Muñoz Maniega S, Nho K, Nugent AC, Nyquist P, Loohuis LMO, Oosterlaan J, Papmeyer M, Pirpamer L, Pütz B, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Ropele S, Rose EJ, Royle NA, Rundek T, Sämann PG, Saremi A, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Trompet S, Vaidya D, Van der Grond J, Van der Lee SJ, Van der Meer D, Van Donkelaar MMJ, Van Eijk KR, Van Erp TGM, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Wolfers T, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Craen AJM, De Geus EJC, De Jager PL, De Zubicaray GI, Deary IJ, Debette S, DeCarli C, Delanty N, Depondt C, DeStefano A, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Enzinger C, Erk S, Espeseth T, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Fornage M, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HHH, Green RC, Gruber O, Gudnason V, Guelfi S, Håberg AK, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Huentelman M, Hulshoff Pol HE, Ikeda M, Jack CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BWJH, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schmidt H, Schofield PR, Sigursson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Tsolaki M, Tzourio C, Uitterlinden AG, Hernández MCV, Van der Brug M, van der Lugt A, van der Wee NJA, Van Haren NEM, van 't Ent D, et al. PMID: 28098162; PMCID: PMC5253632.
      View in: PubMed   Mentions: 147     Fields:    Translation:Humans
    73. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP. J Alzheimers Dis. 2017; 56(2):459-470. Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW, Potkin SG, Lott IT. PMID: 27983553; PMCID: PMC5662115.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    74. Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate. Int J Neuropsychopharmacol. 2017 01 01; 20(1):40-49. Potkin SG, Loze JY, Forray C, Baker RA, Sapin C, Peters-Strickland T, Beillat M, Nylander AG, Hertel P, Nitschky Schmidt S, Eramo A, Hansen K, Naber D. PMID: 27927736; PMCID: PMC5578804.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Association study between the neurexin-1 gene and tardive dyskinesia. Hum Psychopharmacol. 2017 01; 32(1). Lanning R, Lett TA, Tiwari AK, Brandl EJ, de Luca V, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Müller DJ, Remington G, Kennedy JL, Zai CC. PMID: 28120489.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. A novel maturation index based on neonatal diffusion tensor imaging reflects typical perinatal white matter development in humans. Int J Dev Neurosci. 2017 Feb; 56:42-51. Rasmussen JM, Kruggel F, Gilmore JH, Styner M, Entringer S, Consing KN, Potkin SG, Wadhwa PD, Buss C. PMID: 27988340; PMCID: PMC5316374.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. Transl Psychiatry. 2016 12 06; 6(12):e969. Mamdani F, Rollins B, Morgan L, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP, Sequeira PA. PMID: 27922633; PMCID: PMC5315557.
      View in: PubMed   Mentions: 3     Fields:    
    78. Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine. Mol Neuropsychiatry. 2017 Feb; 2(4):185-197. Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL. PMID: 28277565; PMCID: PMC5318922.
      View in: PubMed   Mentions: 5  
    79. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci. 2016 12; 19(12):1569-1582. Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beiser A, Bernard M, Bis JC, Blanken LM, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chauhan G, Chen Q, Ching CR, Cuellar-Partida G, Braber AD, Doan NT, Ehrlich S, Filippi I, Ge T, Giddaluru S, Goldman AL, Gottesman RF, Greven CU, Grimm O, Griswold ME, Guadalupe T, Hass J, Haukvik UK, Hilal S, Hofer E, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liao J, Liewald DC, Lopez LM, Luciano M, Macare C, Marquand A, Matarin M, Mather KA, Mattheisen M, Mazoyer B, McKay DR, McWhirter R, Milaneschi Y, Mirza-Schreiber N, Muetzel RL, Maniega SM, Nho K, Nugent AC, Loohuis LM, Oosterlaan J, Papmeyer M, Pappa I, Pirpamer L, Pudas S, Pütz B, Rajan KB, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Rose EJ, Royle NA, Rundek T, Sämann PG, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Thomson R, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Vaidya D, Van der Grond J, Van der Meer D, Van Donkelaar MM, Van Eijk KR, Van Erp TG, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Woldehawariat G, Wolf C, Wolfers T, Xu B, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Aggarwal NT, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Chen C, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Geus EJ, De Jager PL, de Zubicaray GI, Delanty N, Depondt C, DeStefano AL, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Erk S, Espeseth T, Evans DA, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HH, Grabe HJ, Green RC, Gruber O, Gudnason V, Guelfi S, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Hulshoff Pol HE, Ikeda M, Ikram MK, Jack CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Longstreth WT, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon KL, McMahon FJ, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BW, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schofield PR, Sigurdsson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Srikanth V, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Tiemeier H, Toga AW, Traynor BJ, Troncoso J, Turner JA, Tzourio C, Uitterlinden AG, Hernández MC, Van der Brug M, Van der Lugt A, Van der Wee NJ, Van Duijn CM, Van Haren NE, Van T Ent D, et al. PMID: 27694991; PMCID: PMC5227112.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    80. Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. Neuroimage Clin. 2017; 13:188-200. Kelly C, Castellanos FX, Tomaselli O, Lisdahl K, Tamm L, Jernigan T, Newman E, Epstein JN, Molina BS, Greenhill LL, Potkin SG, Hinshaw S, Swanson JM, MTA Neuroimaging Group. PMID: 27995073; PMCID: PMC5153452.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    81. Go/No Go task performance predicts cortical thickness in the caudal inferior frontal gyrus in young adults with and without ADHD. Brain Imaging Behav. 2016 09; 10(3):880-92. Newman E, Jernigan TL, Lisdahl KM, Tamm L, Tapert SF, Potkin SG, Mathalon D, Molina B, Bjork J, Castellanos FX, Swanson J, Kuperman JM, Bartsch H, Chen CH, Dale AM, Epstein JN, MTA Neuroimaging Group. PMID: 26404018; PMCID: PMC4808505.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    82. ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav. 2016 09; 10(3):761-71. Rasmussen J, Casey BJ, van Erp TG, Tamm L, Epstein JN, Buss C, Bjork JM, Molina BS, Velanova K, Mathalon DH, Somerville L, Swanson JM, Wigal T, Arnold LE, Potkin SG, MTA Neuroimaging Group. PMID: 26489976; PMCID: PMC4840078.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    83. Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophrenia. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug; 2016:4021-4026. Calhoun VD, van Erp TG, Damaraju E, Bustillo J, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Birn F. PMID: 28269167.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. The role of the ITIH3 rs2535629 variant in antipsychotic response. Schizophr Res. 2016 10; 176(2-3):131-135. Brandl EJ, Lett TA, Chowdhury NI, Tiwari AK, Bakanidze G, Meltzer HY, Potkin SG, Lieberman JA, Kennedy JL, Müller DJ. PMID: 27396837.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    85. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis. Int J Neuropsychopharmacol. 2016 05; 19(5). Huang E, Zai CC, Lisoway A, Maciukiewicz M, Felsky D, Tiwari AK, Bishop JR, Ikeda M, Molero P, Ortuno F, Porcelli S, Samochowiec J, Mierzejewski P, Gao S, Crespo-Facorro B, Pelayo-Terán JM, Kaur H, Kukreti R, Meltzer HY, Lieberman JA, Potkin SG, Müller DJ, Kennedy JL. PMID: 26745992; PMCID: PMC4886669.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    86. Biomarkers for drug development in early psychosis: Current issues and promising directions. Eur Neuropsychopharmacol. 2016 06; 26(6):923-37. Goff DC, Romero K, Paul J, Mercedes Perez-Rodriguez M, Crandall D, Potkin SG. PMID: 27005595.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    87. Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine. Hum Psychopharmacol. 2016 Mar; 31(2):121-34. Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL. PMID: 26876050.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    88. Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia. Expert Opin Pharmacother. 2016; 17(3):395-407. Potkin SG, Preda A. PMID: 26864352.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response. Pharmacogenomics. 2016; 17(2):103-9. Huang E, Maciukiewicz M, Zai CC, Tiwari AK, Li J, Potkin SG, Lieberman JA, Meltzer HY, Müller DJ, Kennedy JL. PMID: 26666695.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    90. A 6-week, double-blind, placebo- and haloperidol-controlled, phase II study of lurasidone in patients with acute schizophrenia. Ther Adv Psychopharmacol. 2015 Dec; 5(6):322-31. Potkin SG, Kimura T, Guarino J. PMID: 26834965; PMCID: PMC4722503.
      View in: PubMed   Mentions: 12  
    91. Neuropsychological profile in adult schizophrenia measured with the CMINDS. Psychiatry Res. 2015 Dec 30; 230(3):826-34. van Erp TG, Preda A, Turner JA, Callahan S, Calhoun VD, Bustillo JR, Lim KO, Mueller B, Brown GG, Vaidya JG, McEwen S, Belger A, Voyvodic J, Mathalon DH, Nguyen D, Ford JM, Potkin SG, FBIRN. PMID: 26586142; PMCID: PMC4692593.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    92. Neural Correlates of Schizophrenia Negative Symptoms: Distinct Subtypes Impact Dissociable Brain Circuits. Mol Neuropsychiatry. 2015 Dec; 1(4):191-200. Shaffer JJ, Peterson MJ, McMahon MA, Bizzell J, Calhoun V, van Erp TG, Ford JM, Lauriello J, Lim KO, Manoach DS, McEwen SC, Mathalon DH, O'Leary D, Potkin SG, Preda A, Turner J, Voyvodic J, Wible CG, Belger A. PMID: 27606313; PMCID: PMC4996000.
      View in: PubMed   Mentions: 24  
    93. Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. Transl Psychiatry. 2015 Sep 15; 5:e636. Mamdani F, Rollins B, Morgan L, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP, Sequeira PA. PMID: 26371764; PMCID: PMC5068804.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    94. The Function Biomedical Informatics Research Network Data Repository. Neuroimage. 2016 Jan 01; 124(Pt B):1074-1079. Keator DB, van Erp TGM, Turner JA, Glover GH, Mueller BA, Liu TT, Voyvodic JT, Rasmussen J, Calhoun VD, Lee HJ, Toga AW, McEwen S, Ford JM, Mathalon DH, Diaz M, O'Leary DS, Jeremy Bockholt H, Gadde S, Preda A, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG, FBIRN. PMID: 26364863; PMCID: PMC4651841.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    95. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 04; 21(4):585. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Hulshoff Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. PMID: 26283641; PMCID: PMC5751698.
      View in: PubMed   Mentions: 127     Fields:    
    96. Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia. Schizophr Res. 2015 Oct; 168(1-2):498-504. Naber D, Hansen K, Forray C, Baker RA, Sapin C, Beillat M, Peters-Strickland T, Nylander AG, Hertel P, Andersen HS, Eramo A, Loze JY, Potkin SG. PMID: 26232241.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    97. SchizConnect: Virtual Data Integration in Neuroimaging. Data Integr Life Sci. 2015 Jul; 9162:37-51. Ambite JL, Tallis M, Alpert K, Keator DB, King M, Landis D, Konstantinidis G, Calhoun VD, Potkin SG, Turner JA, Wang L. PMID: 26688837; PMCID: PMC4682903.
      View in: PubMed   Mentions: 10  
    98. Terminology development towards harmonizing multiple clinical neuroimaging research repositories. Data Integr Life Sci. 2015 Jul; 9162:104-117. Turner JA, Pasquerello D, Turner MD, Keator DB, Alpert K, King M, Landis D, Calhoun VD, Potkin SG, Tallis M, Ambite JL, Wang L. PMID: 26688838; PMCID: PMC4682911.
      View in: PubMed   Mentions: 4  
    99. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement. 2015 Jul; 11(7):792-814. Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, Ramanan VK, Foroud TM, Faber KM, Sarwar N, Munsie LM, Hu X, Soares HD, Potkin SG, Thompson PM, Kauwe JS, Kaddurah-Daouk R, Green RC, Toga AW, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 26194313; PMCID: PMC4510473.
      View in: PubMed   Mentions: 164     Fields:    Translation:Humans
    100. SchizConnect: Mediating neuroimaging databases on schizophrenia and related disorders for large-scale integration. Neuroimage. 2016 Jan 01; 124(Pt B):1155-1167. Wang L, Alpert KI, Calhoun VD, Cobia DJ, Keator DB, King MD, Kogan A, Landis D, Tallis M, Turner MD, Potkin SG, Turner JA, Ambite JL. PMID: 26142271; PMCID: PMC4651768.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    101. Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol Psychiatry. 2015 Nov; 20(11):1286-93. Tan Z, Dai W, van Erp TG, Overman J, Demuro A, Digman MA, Hatami A, Albay R, Sontag EM, Potkin KT, Ling S, Macciardi F, Bunney WE, Long JD, Paulsen JS, Ringman JM, Parker I, Glabe C, Thompson LM, Chiu W, Potkin SG. PMID: 26100538; PMCID: PMC4718563.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    102. Multidimensional frequency domain analysis of full-volume fMRI reveals significant effects of age, gender, and mental illness on the spatiotemporal organization of resting-state brain activity. Front Neurosci. 2015; 9:203. Miller RL, Erhardt EB, Agcaoglu O, Allen EA, Michael AM, Turner JA, Bustillo J, Ford JM, Mathalon DH, Van Erp TG, Potkin S, Preda A, Pearlson G, Calhoun VD. PMID: 26136646; PMCID: PMC4468831.
      View in: PubMed   Mentions: 7  
    103. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 Apr; 21(4):547-53. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Hulshoff Pol HE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. PMID: 26033243; PMCID: PMC4668237.
      View in: PubMed   Mentions: 380     Fields:    Translation:Humans
    104. Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. Neuropsychopharmacology. 2015 Nov; 40(12):2705-14. Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya J, Potkin SG, Mathalon DH. PMID: 25944410; PMCID: PMC4864646.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    105. Functional magnetic resonance imaging of motor cortex activation in schizophrenia. J Korean Med Sci. 2015 May; 30(5):625-31. Lee HJ, Preda A, Ford JM, Mathalon DH, Keator DB, van Erp TG, Turner JA, Potkin SG. PMID: 25931795; PMCID: PMC4414648.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    106. Building a roadmap for developing combination therapies for Alzheimer's disease. Expert Rev Neurother. 2015 Mar; 15(3):327-33. Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C. PMID: 25708309; PMCID: PMC4608368.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    107. Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: application to iloperidone. J Psychopharmacol. 2015 Apr; 29(4):372-82. Geerts H, Roberts P, Spiros A, Potkin S. PMID: 25691503.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Common genetic variants influence human subcortical brain structures. Nature. 2015 Apr 09; 520(7546):224-9. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, Bralten J, Brown AA, Chakravarty MM, Chen Q, Ching CR, Cuellar-Partida G, den Braber A, Giddaluru S, Goldman AL, Grimm O, Guadalupe T, Hass J, Woldehawariat G, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kim S, Klein M, Kraemer B, Lee PH, Olde Loohuis LM, Luciano M, Macare C, Mather KA, Mattheisen M, Milaneschi Y, Nho K, Papmeyer M, Ramasamy A, Risacher SL, Roiz-Santiañez R, Rose EJ, Salami A, Sämann PG, Schmaal L, Schork AJ, Shin J, Strike LT, Teumer A, van Donkelaar MM, van Eijk KR, Walters RK, Westlye LT, Whelan CD, Winkler AM, Zwiers MP, Alhusaini S, Athanasiu L, Ehrlich S, Hakobjan MM, Hartberg CB, Haukvik UK, Heister AJ, Hoehn D, Kasperaviciute D, Liewald DC, Lopez LM, Makkinje RR, Matarin M, Naber MA, McKay DR, Needham M, Nugent AC, Pütz B, Royle NA, Shen L, Sprooten E, Trabzuni D, van der Marel SS, van Hulzen KJ, Walton E, Wolf C, Almasy L, Ames D, Arepalli S, Assareh AA, Bastin ME, Brodaty H, Bulayeva KB, Carless MA, Cichon S, Corvin A, Curran JE, Czisch M, de Zubicaray GI, Dillman A, Duggirala R, Dyer TD, Erk S, Fedko IO, Ferrucci L, Foroud TM, Fox PT, Fukunaga M, Gibbs JR, Göring HH, Green RC, Guelfi S, Hansell NK, Hartman CA, Hegenscheid K, Heinz A, Hernandez DG, Heslenfeld DJ, Hoekstra PJ, Holsboer F, Homuth G, Hottenga JJ, Ikeda M, Jack CR, Jenkinson M, Johnson R, Kanai R, Keil M, Kent JW, Kochunov P, Kwok JB, Lawrie SM, Liu X, Longo DL, McMahon KL, Meisenzahl E, Melle I, Mohnke S, Montgomery GW, Mostert JC, Mühleisen TW, Nalls MA, Nichols TE, Nilsson LG, Nöthen MM, Ohi K, Olvera RL, Perez-Iglesias R, Pike GB, Potkin SG, Reinvang I, Reppermund S, Rietschel M, Romanczuk-Seiferth N, Rosen GD, Rujescu D, Schnell K, Schofield PR, Smith C, Steen VM, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Turner JA, Valdés Hernández MC, van 't Ent D, van der Brug M, van der Wee NJ, van Tol MJ, Veltman DJ, Wassink TH, Westman E, Zielke RH, Zonderman AB, Ashbrook DG, Hager R, Lu L, McMahon FJ, Morris DW, Williams RW, Brunner HG, Buckner RL, Buitelaar JK, Cahn W, Calhoun VD, Cavalleri GL, Crespo-Facorro B, Dale AM, Davies GE, Delanty N, Depondt C, Djurovic S, Drevets WC, Espeseth T, Gollub RL, Ho BC, Hoffmann W, Hosten N, Kahn RS, Le Hellard S, Meyer-Lindenberg A, Müller-Myhsok B, Nauck M, Nyberg L, Pandolfo M, Penninx BW, Roffman JL, Sisodiya SM, Smoller JW, van Bokhoven H, van Haren NE, Völzke H, Walter H, Weiner MW, Wen W, White T, Agartz I, Andreassen OA, Blangero J, Boomsma DI, Brouwer RM, Cannon DM, Cookson MR, de Geus EJ, Deary IJ, Donohoe G, Fernández G, Fisher SE, Francks C, Glahn DC, Grabe HJ, Gruber O, Hardy J, Hashimoto R, Hulshoff Pol HE, Jönsson EG, Kloszewska I, Lovestone S, Mattay VS, Mecocci P, McDonald C, McIntosh AM, Ophoff RA, Paus T, Pausova Z, Ryten M, Sachdev PS, Saykin AJ, Simmons A, Singleton A, Soininen H, Wardlaw JM, Weale ME, Weinberger DR, Adams HH, Launer LJ, Seiler S, Schmidt R, Chauhan G, Satizabal CL, Becker JT, Yanek L, van der Lee SJ, Ebling M, Fischl B, Longstreth WT, Greve D, Schmidt H, Nyquist P, Vinke LN, van Duijn CM, Xue L, Mazoyer B, Bis JC, Gudnason V, Seshadri S, Ikram MA, Alzheimer’s Disease Neuroimaging Initiative, CHARGE Consortium, EPIGEN, IMAGEN, SYS, Martin NG, Wright MJ, Schumann G, Franke B, Thompson PM, Medland SE. PMID: 25607358; PMCID: PMC4393366.
      View in: PubMed   Mentions: 411     Fields:    Translation:Humans
    109. Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms. Schizophr Res. 2015 Mar; 162(1-3):169-74. Schooler NR, Buchanan RW, Laughren T, Leucht S, Nasrallah HA, Potkin SG, Abi-Saab D, Berardo CG, Bugarski-Kirola D, Blaettler T, Edgar CJ, Nordstroem AL, O'Gorman C, Garibaldi G. PMID: 25579053.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    110. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics. 2015 Jan; 16(1):5-22. Pouget JG, Gonçalves VF, Nurmi EL, P Laughlin C, Mallya KS, McCracken JT, Aman MG, McDougle CJ, Scahill L, Misener VL, Tiwari AK, Zai CC, Brandl EJ, Felsky D, Leung AQ, Lieberman JA, Meltzer HY, Potkin SG, Niedling C, Steimer W, Leucht S, Knight J, Müller DJ, Kennedy JL. PMID: 25560467.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. Schizophr Bull. 2015 Sep; 41(5):1133-42. Gupta CN, Calhoun VD, Rachakonda S, Chen J, Patel V, Liu J, Segall J, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar J, Fisher SE, Fernandez G, van Erp TG, Potkin S, Ford J, Mathalon D, McEwen S, Lee HJ, Mueller BA, Greve DN, Andreassen O, Agartz I, Gollub RL, Sponheim SR, Ehrlich S, Wang L, Pearlson G, Glahn DC, Sprooten E, Mayer AR, Stephen J, Jung RE, Canive J, Bustillo J, Turner JA. PMID: 25548384; PMCID: PMC4535628.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    112. Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia. CNS Spectr. 2016 Apr; 21(2):199-206. Potkin SG, Bugarski-Kirola D, Edgar CJ, Soliman S, Le Scouiller S, Kunovac J, Miguel Velasco E, Garibaldi GM. PMID: 25269787; PMCID: PMC4825104.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    113. Imaging genetics approaches to identify mechanisms in severe mental illness. Biol Psychiatry. 2014 Sep 15; 76(6):436-7. Potkin SG, Macciardi F, van Erp TG. PMID: 25149350.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    114. Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia. Neuroimage Clin. 2014; 5:298-308. Damaraju E, Allen EA, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TG, Calhoun VD. PMID: 25161896; PMCID: PMC4141977.
      View in: PubMed   Mentions: 460     Fields:    Translation:Humans
    115. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav. 2014 Jun; 8(2):183-207. Shen L, Thompson PM, Potkin SG, Bertram L, Farrer LA, Foroud TM, Green RC, Hu X, Huentelman MJ, Kim S, Kauwe JS, Li Q, Liu E, Macciardi F, Moore JH, Munsie L, Nho K, Ramanan VK, Risacher SL, Stone DJ, Swaminathan S, Toga AW, Weiner MW, Saykin AJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 24092460; PMCID: PMC3976843.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    116. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 2014 Jun; 8(2):153-82. Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann O, Binder EB, Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J, Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR, Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty MM, Chang KD, Ching CR, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G, Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJ, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT, Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC, Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur RE, Gur RC, Göring HH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ, Hulshoff Pol HE, Hwang KS, Jack CR, Jenkinson M, Johnston C, Jönsson EG, Kahn RS, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JB, Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen MW, Macqueen GM, Malt UF, Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M, Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L, Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM, Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee NJ, van Eijk K, van Erp TG, van Haren NE, van 't Ent D, van Tol MJ, Valdés Hernández MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR, et al. PMID: 24399358; PMCID: PMC4008818.
      View in: PubMed   Mentions: 349     Fields:    Translation:Humans
    117. A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia. Clin Schizophr Relat Psychoses. 2017 Winter; 10(4):211-221. Potkin SG, Bera R, Eramo A, Lau G. PMID: 24846880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    118. Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. Schizophr Bull. 2015 Jan; 41(1):223-32. Ford JM, Palzes VA, Roach BJ, Potkin SG, van Erp TG, Turner JA, Mueller BA, Calhoun VD, Voyvodic J, Belger A, Bustillo J, Vaidya JG, Preda A, McEwen SC, Functional Imaging Biomedical Informatics Research Network, Mathalon DH. PMID: 24619536; PMCID: PMC4266287.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    119. Transposable elements and psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2014 Apr; 165B(3):201-16. Guffanti G, Gaudi S, Fallon JH, Sobell J, Potkin SG, Pato C, Macciardi F. PMID: 24585726.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    120. A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Res. 2014 Apr 30; 222(1-2):10-6. van Erp TG, Greve DN, Rasmussen J, Turner J, Calhoun VD, Young S, Mueller B, Brown GG, McCarthy G, Glover GH, Lim KO, Bustillo JR, Belger A, McEwen S, Voyvodic J, Mathalon DH, Keator D, Preda A, Nguyen D, Ford JM, Potkin SG. PMID: 24650452; PMCID: PMC4059082.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    121. A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimers Dement. 2014 Sep; 10(5):571-81. Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT. PMID: 24411134.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCellsCTClinical Trials
    122. Converting positive and negative symptom scores between PANSS and SAPS/SANS. Schizophr Res. 2014 Jan; 152(1):289-94. van Erp TG, Preda A, Nguyen D, Faziola L, Turner J, Bustillo J, Belger A, Lim KO, McEwen S, Voyvodic J, Mathalon DH, Ford J, Potkin SG. PMID: 24332632; PMCID: PMC3966195.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    123. Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. Am J Psychiatry. 2013 Nov; 170(11):1335-44. Agid O, Siu CO, Potkin SG, Kapur S, Watsky E, Vanderburg D, Zipursky RB, Remington G. PMID: 23896810.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    124. Brown adipose tissue quantification in human neonates using water-fat separated MRI. PLoS One. 2013; 8(10):e77907. Rasmussen JM, Entringer S, Nguyen A, van Erp TG, Burns J, Guijarro A, Oveisi F, Swanson JM, Piomelli D, Wadhwa PD, Buss C, Potkin SG. PMID: 24205024; PMCID: PMC3813555.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    125. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia. BMC Psychiatry. 2013 Oct 16; 13:261. Potkin S, Bera R, Zubek D, Lau G. PMID: 24131801; PMCID: PMC3819472.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    126. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder. CNS Spectr. 2014 Apr; 19(2):176-81. Potkin SG, Keator DB, Kesler-West ML, Nguyen DD, van Erp TG, Mukherjee J, Shah N, Preda A. PMID: 24073841.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    127. Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: a pooled analysis. Schizophr Res. 2013 Nov; 150(2-3):442-9. Potkin SG, Phiri P, Szegedi A, Zhao J, Alphs L, Cazorla P. PMID: 24075603.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    128. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia. J Psychiatr Res. 2013 Nov; 47(11):1760-5. Zai CC, Tiwari AK, Mazzoco M, de Luca V, Müller DJ, Shaikh SA, Lohoff FW, Freeman N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL. PMID: 24018103.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    129. A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front Neurosci. 2013; 7:137. Turner JA, Damaraju E, van Erp TG, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, Bustillo J, McEwen S, Potkin SG, Calhoun VD. PMID: 23964193; PMCID: PMC3737471.
      View in: PubMed   Mentions: 90  
    130. Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry. 2014 Mar 01; 75(5):398-405. van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon DH, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG. PMID: 23910899; PMCID: PMC4428556.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    131. Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment? Pharmacogenomics. 2013 Aug; 14(11):1273-81. Chan LF, Zai C, Monda M, Potkin S, Kennedy JL, Remington G, Lieberman J, Meltzer HY, De Luca V. PMID: 23930674.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    132. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole. Curr Med Res Opin. 2013 Oct; 29(10):1241-51. Potkin SG, Raoufinia A, Mallikaarjun S, Bricmont P, Peters-Strickland T, Kasper W, Baker RA, Eramo A, Sanchez R, McQuade R. PMID: 23822566.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    133. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res. 2013 Sep; 47(9):1215-21. Guella I, Sequeira A, Rollins B, Morgan L, Torri F, van Erp TG, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Bunney WE, Potkin SG, Macciardi F, Vawter MP. PMID: 23786914; PMCID: PMC3753093.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    134. An application of item response theory to fMRI data: prospects and pitfalls. Psychiatry Res. 2013 Jun 30; 212(3):167-74. Thomas ML, Brown GG, Thompson WK, Voyvodic J, Greve DN, Turner JA, Mathalon DH, Ford J, Wible CG, Potkin SG, FBIRN. PMID: 23642468; PMCID: PMC3775707.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    135. Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. Genomics. 2013 Aug; 102(2):112-22. Guffanti G, Torri F, Rasmussen J, Clark AP, Lakatos A, Turner JA, Fallon JH, Saykin AJ, Weiner M, ADNI the Alzheimer's Disease Neuroimaging Initiative, Vawter MP, Knowles JA, Potkin SG, Macciardi F. PMID: 23583670; PMCID: PMC4012421.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    136. Gating of a novel brain potential is associated with perceptual anomalies in bipolar disorder. Bipolar Disord. 2013 May; 15(3):314-25. Patterson JV, Sandman CA, Jin Y, Kemp AS, Potkin SG, Bunney WE. PMID: 23531082.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial. Schizophr Res. 2013 Apr; 145(1-3):101-9. Loebel A, Cucchiaro J, Sarma K, Xu L, Hsu C, Kalali AH, Pikalov A, Potkin SG. PMID: 23415311.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    138. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone. J Clin Psychopharmacol. 2013 Feb; 33(1):3-10. Potkin SG, Preskorn S, Hochfeld M, Meng X. PMID: 23277250.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    139. Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes. Proc Natl Acad Sci U S A. 2013 Feb 19; 110(8):3077-82. Sontag EM, Joachimiak LA, Tan Z, Tomlinson A, Housman DE, Glabe CG, Potkin SG, Frydman J, Thompson LM. PMID: 23365139; PMCID: PMC3581981.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    140. Next generation sequence analysis and computational genomics using graphical pipeline workflows. Genes (Basel). 2012 Aug 30; 3(3):545-75. Torri F, Dinov ID, Zamanyan A, Hobel S, Genco A, Petrosyan P, Clark AP, Liu Z, Eggert P, Pierce J, Knowles JA, Ames J, Kesselman C, Toga AW, Potkin SG, Vawter MP, Macciardi F. PMID: 23139896; PMCID: PMC3490498.
      View in: PubMed   Mentions: 22     Fields:    
    141. Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classification. Hum Brain Mapp. 2014 Jan; 35(1):38-52. Keator DB, Fallon JH, Lakatos A, Fowlkes CC, Potkin SG, Ihler A, Alzheimer's Disease Neuroimaging Initiative. PMID: 22847891; PMCID: PMC4745890.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    142. Heritability of multivariate gray matter measures in schizophrenia. Twin Res Hum Genet. 2012 Jun; 15(3):324-35. Turner JA, Calhoun VD, Michael A, van Erp TG, Ehrlich S, Segall JM, Gollub RL, Csernansky J, Potkin SG, Ho BC, Bustillo J, Schulz SC, Wang L. PMID: 22856368; PMCID: PMC3694574.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    143. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 01; 39(1):96-101. Zai GC, Zai CC, Chowdhury NI, Tiwari AK, Souza RP, Lieberman JA, Meltzer HY, Potkin SG, Müller DJ, Kennedy JL. PMID: 22642961.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    144. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012 Apr 15; 44(5):552-61. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, Domin M, Grimm O, Hollinshead M, Holmes AJ, Homuth G, Hottenga JJ, Langan C, Lopez LM, Hansell NK, Hwang KS, Kim S, Laje G, Lee PH, Liu X, Loth E, Lourdusamy A, Mattingsdal M, Mohnke S, Maniega SM, Nho K, Nugent AC, O'Brien C, Papmeyer M, Pütz B, Ramasamy A, Rasmussen J, Rijpkema M, Risacher SL, Roddey JC, Rose EJ, Ryten M, Shen L, Sprooten E, Strengman E, Teumer A, Trabzuni D, Turner J, van Eijk K, van Erp TG, van Tol MJ, Wittfeld K, Wolf C, Woudstra S, Aleman A, Alhusaini S, Almasy L, Binder EB, Brohawn DG, Cantor RM, Carless MA, Corvin A, Czisch M, Curran JE, Davies G, de Almeida MA, Delanty N, Depondt C, Duggirala R, Dyer TD, Erk S, Fagerness J, Fox PT, Freimer NB, Gill M, Göring HH, Hagler DJ, Hoehn D, Holsboer F, Hoogman M, Hosten N, Jahanshad N, Johnson MP, Kasperaviciute D, Kent JW, Kochunov P, Lancaster JL, Lawrie SM, Liewald DC, Mandl R, Matarin M, Mattheisen M, Meisenzahl E, Melle I, Moses EK, Mühleisen TW, Nauck M, Nöthen MM, Olvera RL, Pandolfo M, Pike GB, Puls R, Reinvang I, Rentería ME, Rietschel M, Roffman JL, Royle NA, Rujescu D, Savitz J, Schnack HG, Schnell K, Seiferth N, Smith C, Steen VM, Valdés Hernández MC, Van den Heuvel M, van der Wee NJ, Van Haren NE, Veltman JA, Völzke H, Walker R, Westlye LT, Whelan CD, Agartz I, Boomsma DI, Cavalleri GL, Dale AM, Djurovic S, Drevets WC, Hagoort P, Hall J, Heinz A, Jack CR, Foroud TM, Le Hellard S, Macciardi F, Montgomery GW, Poline JB, Porteous DJ, Sisodiya SM, Starr JM, Sussmann J, Toga AW, Veltman DJ, Walter H, Weiner MW, Alzheimer's Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study Group, Bis JC, Ikram MA, Smith AV, Gudnason V, Tzourio C, Vernooij MW, Launer LJ, DeCarli C, Seshadri S, Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium, Andreassen OA, Apostolova LG, Bastin ME, Blangero J, Brunner HG, Buckner RL, Cichon S, Coppola G, de Zubicaray GI, Deary IJ, Donohoe G, de Geus EJ, Espeseth T, Fernández G, Glahn DC, Grabe HJ, Hardy J, Hulshoff Pol HE, Jenkinson M, Kahn RS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meyer-Lindenberg A, Morris DW, Müller-Myhsok B, Nichols TE, Ophoff RA, Paus T, Pausova Z, Penninx BW, Potkin SG, Sämann PG, Saykin AJ, Schumann G, Smoller JW, Wardlaw JM, Weale ME, Martin NG, Franke B, Wright MJ, Thompson PM, Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium. PMID: 22504417; PMCID: PMC3635491.
      View in: PubMed   Mentions: 350     Fields:    Translation:HumansCells
    145. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012 Mar; 6(1):1-15. Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR, Weiner MW, Saykin AJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 21901424; PMCID: PMC3256261.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    146. An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci. 2012; 6:21. Liu J, Ghassemi MM, Michael AM, Boutte D, Wells W, Perrone-Bizzozero N, Macciardi F, Mathalon DH, Ford JM, Potkin SG, Turner JA, Calhoun VD. PMID: 22371699; PMCID: PMC3284145.
      View in: PubMed   Mentions: 15  
    147. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative, Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, et al. PMID: 22343285; PMCID: PMC3309762.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    148. Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging. 2012 Jul; 36(1):39-54. Glover GH, Mueller BA, Turner JA, van Erp TG, Liu TT, Greve DN, Voyvodic JT, Rasmussen J, Brown GG, Keator DB, Calhoun VD, Lee HJ, Ford JM, Mathalon DH, Diaz M, O'Leary DS, Gadde S, Preda A, Lim KO, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG. PMID: 22314879; PMCID: PMC3349791.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    149. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry. 2012 May; 17(5):486-93. Hornig M, Briese T, Licinio J, Khabbaz RF, Altshuler LL, Potkin SG, Schwemmle M, Siemetzki U, Mintz J, Honkavuori K, Kraemer HC, Egan MF, Whybrow PC, Bunney WE, Lipkin WI. PMID: 22290118; PMCID: PMC3622588.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    150. A system architecture for sharing de-identified, research-ready brain scans and health information across clinical imaging centers. Stud Health Technol Inform. 2012; 175:19-28. Chervenak AL, van Erp TG, Kesselman C, D'Arcy M, Sobell J, Keator D, Dahm L, Murry J, Law M, Hasso A, Ames J, Macciardi F, Potkin SG. PMID: 22941984; PMCID: PMC4478050.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    151. Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27; 37(1):62-75. Hwang R, Tiwari AK, Zai CC, Felsky D, Remington E, Wallace T, Tong RP, Souza RP, Oh G, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL. PMID: 22203087.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    152. Alpha EEG guided TMS in schizophrenia. Brain Stimul. 2012 Oct; 5(4):560-8. Jin Y, Kemp AS, Huang Y, Thai TM, Liu Z, Xu W, He H, Potkin SG. PMID: 22019083.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    153. Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochim Biophys Acta. 2012 Mar; 1822(3):457-66. Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG, Alzheimer's Disease Neuroimaging Initiative. PMID: 21958592; PMCID: PMC5849233.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    154. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response. Schizophr Res. 2011 Nov; 132(2-3):121-4. Lett TA, Tiwari AK, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN, Kennedy JL, Müller DJ. PMID: 21890328.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    155. Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder. Schizophr Res. 2011 Nov; 132(2-3):101-7. Potkin SG, Ogasa M, Cucchiaro J, Loebel A. PMID: 21889878.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    156. Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia. Schizophr Res. 2011 Nov; 132(2-3):108-13. Potkin S, Agid O, Siu C, Watsky E, Vanderburg D, Remington G. PMID: 21873032.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    157. Assessment of psychological pain in major depressive episodes. J Psychiatr Res. 2011 Nov; 45(11):1504-10. Mee S, Bunney BG, Bunney WE, Hetrick W, Potkin SG, Reist C. PMID: 21831397.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    158. Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. Int J Alzheimers Dis. 2011; 2011:729478. Swaminathan S, Kim S, Shen L, Risacher SL, Foroud T, Pankratz N, Potkin SG, Huentelman MJ, Craig DW, Weiner MW, Saykin AJ. PMID: 21660214; PMCID: PMC3109875.
      View in: PubMed   Mentions: 36  
    159. Enabling collaborative research using the Biomedical Informatics Research Network (BIRN). J Am Med Inform Assoc. 2011 Jul-Aug; 18(4):416-22. Helmer KG, Ambite JL, Ames J, Ananthakrishnan R, Burns G, Chervenak AL, Foster I, Liming L, Keator D, Macciardi F, Madduri R, Navarro JP, Potkin S, Rosen B, Ruffins S, Schuler R, Turner JA, Toga A, Williams C, Kesselman C, Biomedical Informatics Research Network. PMID: 21515543; PMCID: PMC3128398.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    160. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011 Apr 15; 12:99. Weng L, Macciardi F, Subramanian A, Guffanti G, Potkin SG, Yu Z, Xie X. PMID: 21496265; PMCID: PMC3102637.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    161. Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 2011 Jun 15; 56(4):1875-91. Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, Kim S, Pankratz N, Foroud T, Huentelman MJ, Potkin SG, Jack CR, Weiner MW, Toga AW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. PMID: 21497199; PMCID: PMC3366726.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    162. Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response. Pharmacogenomics. 2011 Feb; 12(2):277-91. Hwang R, Souza RP, Tiwari AK, Zai CC, Müller DJ, Potkin SG, Lieberman JA, Meltze HY, Kennedy JL. PMID: 21332319.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    163. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia. Pharmacogenomics J. 2012 Jun; 12(3):260-6. Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Müller DJ, Kennedy JL. PMID: 21266946.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    164. Asenapine: a clinical overview. J Clin Psychiatry. 2011; 72 Suppl 1:14-8. Potkin SG. PMID: 22217438.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    165. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011 Jan 04; 76(1):69-79. Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. PMID: 21123754; PMCID: PMC3030225.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    166. A novel method for quantifying scanner instability in fMRI. Magn Reson Med. 2011 Apr; 65(4):1053-61. Greve DN, Mueller BA, Liu T, Turner JA, Voyvodic J, Yetter E, Diaz M, McCarthy G, Wallace S, Roach BJ, Ford JM, Mathalon DH, Calhoun VD, Wible CG, Brown GG, Potkin SG, Glover G. PMID: 21413069; PMCID: PMC3117086.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    167. Multisite reliability of cognitive BOLD data. Neuroimage. 2011 Feb 01; 54(3):2163-75. Brown GG, Mathalon DH, Stern H, Ford J, Mueller B, Greve DN, McCarthy G, Voyvodic J, Glover G, Diaz M, Yetter E, Ozyurt IB, Jorgensen KW, Wible CG, Turner JA, Thompson WK, Potkin SG, Function Biomedical Informatics Research Network. PMID: 20932915; PMCID: PMC3009557.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    168. Using new antipsychotics in your clinical practice. J Clin Psychiatry. 2010 Oct; 71(10):e101. Potkin SG, Preda A, Kalali AH, Harvey PD. PMID: 21062611.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    169. The catechol-O-methyl-transferase gene in tardive dyskinesia. World J Biol Psychiatry. 2010 Sep; 11(6):803-12. Zai CC, Tiwari AK, Müller DJ, De Luca V, Shinkai T, Shaikh S, Ni X, Sibony D, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL. PMID: 20586531.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    170. A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. J Clin Psychopharmacol. 2010 Aug; 30(4):425-30. Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S. PMID: 20571437.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    171. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia. J Clin Psychiatry. 2011 Feb; 72(2):194-204. Kane JM, Potkin SG, Daniel DG, Buckley PF. PMID: 20673553.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    172. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. J Psychiatr Res. 2011 Jan; 45(1):64-75. DeBattista C, Kinrys G, Hoffman D, Goldstein C, Zajecka J, Kocsis J, Teicher M, Potkin S, Preda A, Multani G, Brandt L, Schiller M, Iosifescu D, Fava M. PMID: 20598710.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    173. Identifying gene regulatory networks in schizophrenia. Neuroimage. 2010 Nov 15; 53(3):839-47. Potkin SG, Macciardi F, Guffanti G, Fallon JH, Wang Q, Turner JA, Lakatos A, Miles MF, Lander A, Vawter MP, Xie X. PMID: 20600988; PMCID: PMC3055795.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimals
    174. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging. 2010 Aug; 31(8):1355-63. Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, Weiner M, Macciardi F, Schork N, Wallace DC, Potkin SG, Alzheimer's Disease Neuroimaging Initiative. PMID: 20538375; PMCID: PMC2918801.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    175. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement. 2010 May; 6(3):265-73. Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 20451875; PMCID: PMC2868595.
      View in: PubMed   Mentions: 254     Fields:    Translation:Humans
    176. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010 May 04; 107(18):8404-9. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. PMID: 20404173; PMCID: PMC2889537.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    177. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage. 2010 Jun; 51(2):542-54. Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CR, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. PMID: 20197096; PMCID: PMC2856746.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    178. Voxelwise genome-wide association study (vGWAS). Neuroimage. 2010 Nov 15; 53(3):1160-74. Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P, Alzheimer's Disease Neuroimaging Initiative. PMID: 20171287; PMCID: PMC2900429.
      View in: PubMed   Mentions: 146     Fields:    Translation:Humans
    179. Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia. Psychiatr Genet. 2010 Feb; 20(1):39-43. Novak G, Gallo A, Zai CC, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN, Remington G, Kennedy JL, Levesque D, Le Foll B. PMID: 20010315.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    180. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage. 2010 Nov 15; 53(3):1051-63. Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR, Weiner MW, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. PMID: 20100581; PMCID: PMC2892122.
      View in: PubMed   Mentions: 205     Fields:    Translation:Humans
    181. Working memory circuitry in schizophrenia shows widespread cortical inefficiency and compensation. Schizophr Res. 2010 Mar; 117(1):42-51. Kim MA, Tura E, Potkin SG, Fallon JH, Manoach DS, Calhoun VD, FBIRN, Turner JA. PMID: 20096539; PMCID: PMC2821986.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    182. Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Pharmacogenomics J. 2010 Jun; 10(3):200-18. Hwang R, Zai C, Tiwari A, Müller DJ, Arranz MJ, Morris AG, McKenna PJ, Munro J, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL. PMID: 20029384.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    183. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects. Hum Psychopharmacol. 2009 Dec; 24(8):676-9. Souza RP, Tampakeras M, Basile V, Shinkai T, Rosa DV, Potkin S, Meltzer HY, Lieberman JA, Romano-Silva MA, Kennedy JL. PMID: 19946932.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    184. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp. 2009 Nov; 30(11):3795-811. Kim DI, Manoach DS, Mathalon DH, Turner JA, Mannell M, Brown GG, Ford JM, Gollub RL, White T, Wible C, Belger A, Bockholt HJ, Clark VP, Lauriello J, O'Leary D, Mueller BA, Lim KO, Andreasen N, Potkin SG, Calhoun VD. PMID: 19434601; PMCID: PMC3058491.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    185. Dropouts and missing data in psychiatric clinical trials. Am J Psychiatry. 2009 Nov; 166(11):1295; author reply 1295-6. Potkin SG, Siu CO. PMID: 19884237.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    186. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 01; 34(1):50-6. Zai CC, Tiwari AK, Basile V, de Luca V, Müller DJ, Voineskos AN, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. PMID: 19778569.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    187. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One. 2009 Aug 07; 4(8):e6501. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F, Alzheimer's Disease Neuroimaging Initiative. PMID: 19668339; PMCID: PMC2719581.
      View in: PubMed   Mentions: 208     Fields:    Translation:Humans
    188. Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia. J Clin Psychiatry. 2009 Jun; 70(6):801-9. Volpi S, Potkin SG, Malhotra AK, Licamele L, Lavedan C. PMID: 19573479.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    189. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. Int J Neuropsychopharmacol. 2009 Oct; 12(9):1233-48. Potkin SG, Weiden PJ, Loebel AD, Warrington LE, Watsky EJ, Siu CO. PMID: 19419595.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    190. Nicotine-induced brain metabolism associated with anger provocation. Behav Brain Funct. 2009 Apr 24; 5:19. Gehricke JG, Potkin SG, Leslie FM, Loughlin SE, Whalen CK, Jamner LD, Mbogori J, Fallon JH. PMID: 19393039; PMCID: PMC2680866.
      View in: PubMed   Mentions: 5     Fields:    
    191. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009 Aug 01; 66(3):298-301. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, Gillin JC, Potkin SG, Bunney WE. PMID: 19358978.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    192. MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis. Schizophr Res. 2009 May; 110(1-3):200-1. De Luca V, Souza RP, Viggiano E, Zai CC, Shinkai T, Lieberman JA, Potkin SG, Meltzer HY, Remington G, Kennedy JL. PMID: 19282152.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    193. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients. Pharmacogenomics J. 2009 Jun; 9(3):168-74. Zai CC, Tiwari AK, Basile V, De Luca V, Müller DJ, King N, Voineskos AN, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. PMID: 19238168.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    194. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur Neuropsychopharmacol. 2009 May; 19(5):317-28. Zai CC, Tiwari AK, De Luca V, Müller DJ, Bulgin N, Hwang R, Zai GC, King N, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL. PMID: 19217756.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    195. Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Inj. 2009 Feb; 23(2):123-32. Silver JM, Koumaras B, Meng X, Potkin SG, Reyes PF, Harvey PD, Katz DI, Gunay I, Arciniegas DB. PMID: 19191091.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    196. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry. 2009; 14(4-5):391-418. Potkin SG, Turner JA, Guffanti G, Lakatos A, Torri F, Keator DB, Macciardi F. PMID: 19634037; PMCID: PMC3037334.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    197. Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study. Schizophr Bull. 2009 Jan; 35(1):67-81. Kim DI, Mathalon DH, Ford JM, Mannell M, Turner JA, Brown GG, Belger A, Gollub R, Lauriello J, Wible C, O'Leary D, Lim K, Toga A, Potkin SG, Birn F, Calhoun VD. PMID: 19074498; PMCID: PMC2643962.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    198. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Mol Psychiatry. 2009 Apr; 14(4):416-28. Potkin SG, Turner JA, Fallon JA, Lakatos A, Keator DB, Guffanti G, Macciardi F. PMID: 19065146; PMCID: PMC3254586.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    199. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull. 2009 Jan; 35(1):19-31. Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, Manoach DS, Belger A, Diaz M, Wible CG, Ford JM, Mathalon DH, Gollub R, Lauriello J, O'Leary D, van Erp TG, Toga AW, Preda A, Lim KO, FBIRN. PMID: 19042912; PMCID: PMC2643959.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    200. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull. 2009 Jan; 35(1):96-108. Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F, FBIRN. PMID: 19023125; PMCID: PMC2643953.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    201. Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortium. Schizophr Bull. 2009 Jan; 35(1):15-8. Potkin SG, Ford JM. PMID: 19023124; PMCID: PMC2643955.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    202. Brain-performance correlates of working memory retrieval in schizophrenia: a cognitive modeling approach. Schizophr Bull. 2009 Jan; 35(1):32-46. Brown GG, McCarthy G, Bischoff-Grethe A, Ozyurt B, Greve D, Potkin SG, Turner JA, Notestine R, Calhoun VD, Ford JM, Mathalon D, Manoach DS, Gadde S, Glover GH, Wible CG, Belger A, Gollub RL, Lauriello J, O'Leary D, Lim KO. PMID: 19023127; PMCID: PMC2643949.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    203. Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull. 2009 Jan; 35(1):58-66. Ford JM, Roach BJ, Jorgensen KW, Turner JA, Brown GG, Notestine R, Bischoff-Grethe A, Greve D, Wible C, Lauriello J, Belger A, Mueller BA, Calhoun V, Preda A, Keator D, O'Leary DS, Lim KO, Glover G, Potkin SG, FBIRN, Mathalon DH. PMID: 18987102; PMCID: PMC2643968.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    204. fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull. 2009 Jan; 35(1):47-57. Wible CG, Lee K, Molina I, Hashimoto R, Preus AP, Roach BJ, Ford JM, Mathalon DH, McCarthey G, Turner JA, Potkin SG, O'Leary D, Belger A, Diaz M, Voyvodic J, Brown GG, Notestine R, Greve D, Lauriello J, FBIRN. PMID: 18990710; PMCID: PMC2643958.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    205. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia. Schizophr Res. 2008 Dec; 106(2-3):248-52. Zai CC, Romano-Silva MA, Hwang R, Zai GC, Deluca V, Müller DJ, King N, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL. PMID: 18838251.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    206. What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull. 2010 May; 36(3):504-9. Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Dubé S, Ereshefsky L, Gharabawi G, Leon AC, Lepine JP, Potkin SG, Vermeulen A. PMID: 18723840; PMCID: PMC2879679.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    207. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp. 2008 Aug; 29(8):958-72. Friedman L, Stern H, Brown GG, Mathalon DH, Turner J, Glover GH, Gollub RL, Lauriello J, Lim KO, Cannon T, Greve DN, Bockholt HJ, Belger A, Mueller B, Doty MJ, He J, Wells W, Smyth P, Pieper S, Kim S, Kubicki M, Vangel M, Potkin SG. PMID: 17636563; PMCID: PMC3670112.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    208. Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br Med Bull. 2008; 86:23-32. Bunney JN, Potkin SG. PMID: 18487629.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    209. Multivariate analyses suggest genetic impacts on neurocircuitry in schizophrenia. Neuroreport. 2008 Apr 16; 19(6):603-7. Tura E, Turner JA, Fallon JH, Kennedy JL, Potkin SG. PMID: 18382271; PMCID: PMC2967451.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    210. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies. J Clin Psychopharmacol. 2008 Apr; 28(2 Suppl 1):S4-11. Potkin SG, Litman RE, Torres R, Wolfgang CD. PMID: 18334911.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    211. New advances in the treatment of schizophrenia. Introduction. J Clin Psychopharmacol. 2008 Apr; 28(2 Suppl 1):S1-3. Potkin SG. PMID: 18334907.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    212. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res. 2008 Mar 15; 158(2):226-47. Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H, Potkin S, Bunney WE. PMID: 18187207.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    213. Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls. Neuroimage. 2008 Apr 15; 40(3):1181-94. Friedman L, Turner JA, Stern H, Mathalon DH, Trondsen LC, Potkin SG. PMID: 18289881; PMCID: PMC2312339.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    214. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res. 2007 Nov; 9 Suppl 4:S523-36. Gehricke JG, Loughlin SE, Whalen CK, Potkin SG, Fallon JH, Jamner LD, Belluzzi JD, Leslie FM. PMID: 18067030.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    215. Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial. J Clin Psychiatry. 2007 Oct; 68(10):1492-500. Potkin SG, Cohen M, Panagides J. PMID: 17960962.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    216. Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study. J Clin Psychiatry. 2007 Sep; 68(9):1333-8. Loebel AD, Khanna S, Rajadhyaksha S, Siu CO, Giller E, Potkin SG. PMID: 17915970.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    217. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 2007 Jun; 6(6):501-12. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R. PMID: 17509485.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCTClinical Trials
    218. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods. 2007 Jul 30; 163(2):295-309. Atz M, Walsh D, Cartagena P, Li J, Evans S, Choudary P, Overman K, Stein R, Tomita H, Potkin S, Myers R, Watson SJ, Jones EG, Akil H, Bunney WE, Vawter MP, Members of National Institute of Mental Health Conte Center and Pritzker Neuropsychiatric Disorders . PMID: 17512057; PMCID: PMC3835340.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    219. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse. 2007 Jan; 61(1):29-36. Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. PMID: 17068780.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    220. Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J Psychopharmacol. 2007 Sep; 21(7):718-27. Hwang R, Shinkai T, De Luca V, Ni X, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL. PMID: 17092969.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    221. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J Nucl Med. 2006 Oct; 47(10):1697-706. Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. PMID: 17015907.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    222. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 2006 Sep 12; 67(5):748-55. Silver JM, Koumaras B, Chen M, Mirski D, Potkin SG, Reyes P, Warden D, Harvey PD, Arciniegas D, Katz DI, Gunay I. PMID: 16966534.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    223. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Int J Neuropsychopharmacol. 2007 Oct; 10(5):639-51. Zai CC, Hwang RW, De Luca V, Müller DJ, King N, Zai GC, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. PMID: 16959057.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    224. Alpha EEG predicts visual reaction time. Int J Neurosci. 2006 Sep; 116(9):1035-44. Jin Y, O'Halloran JP, Plon L, Sandman CA, Potkin SG. PMID: 16861166.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    225. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry. 2006 Aug; 14(8):704-15. Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S. PMID: 16861375.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    226. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res. 2006 Jul; 85(1-3):254-65. Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. PMID: 16797162.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    227. Psychological pain: a review of evidence. J Psychiatr Res. 2006 Dec; 40(8):680-90. Mee S, Bunney BG, Reist C, Potkin SG, Bunney WE. PMID: 16725157.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    228. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol. 2006 Apr; 33(3):295-304. Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. PMID: 16631077.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    229. Three-month change in cerebral glucose metabolism in patients with nonarteritic ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2006 Aug; 244(8):1052-5. Bose S, Mok AC, Fallon JH, Potkin SG. PMID: 16411101.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    230. A general XML schema and SPM toolbox for storage of neuro-imaging results and anatomical labels. Neuroinformatics. 2006; 4(2):199-212. Keator DB, Gadde S, Grethe JS, Taylor DV, Potkin SG, FIRST BIRN. PMID: 16845169.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    231. Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics. 2006; 4(1):21-49. Turner JA, Smyth P, Macciardi F, Fallon JH, Kennedy JL, Potkin SG. PMID: 16595857.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    232. A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia. Drugs Aging. 2006; 23(3):241-9. Potkin SG, Alva G, Gunay I, Koumaras B, Chen M, Mirski D. PMID: 16608379.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    233. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia. Neurosci Lett. 2005 Nov 11; 388(2):116-20. Shinkai T, De Luca V, Hwang R, Matsumoto C, Hori H, Ohmori O, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Nakamura J, Kennedy JL. PMID: 16039055.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    234. Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment. Eur Neuropsychopharmacol. 2006 May; 16(4):248-59. Hwang R, Shinkai T, Deluca V, Macciardi F, Potkin S, Meltzer HY, Kennedy JL. PMID: 16278074.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    235. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. Schizophr Bull. 2006 Jul; 32(3):556-61. Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, Carreon D, Bunney WE. PMID: 16254067; PMCID: PMC2632240.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    236. Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl). 2005 Aug; 181(1):179-87. Hwang R, Shinkai T, De Luca V, Müller DJ, Ni X, Macciardi F, Potkin S, Lieberman JA, Meltzer HY, Kennedy JL. PMID: 15830237.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    237. Psychometric evaluation of the Readiness for Discharge Questionnaire. Schizophr Res. 2005 Dec 15; 80(2-3):203-12. Potkin SG, Gharabawi GM, Greenspan AJ, Rupnow MF, Kosik-Gonzalez C, Remington G, Ruetsch C, Revicki D. PMID: 16102943.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    238. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 2006 Feb; 9(1):101-24. Lane RM, Potkin SG, Enz A. PMID: 16083515.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansAnimalsCells
    239. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol. 2005 Aug; 25(4):301-10. Potkin SG, Keck PE, Segal S, Ice K, English P. PMID: 16012271.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    240. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005 May; 11(5):551-5. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J. PMID: 15852017.
      View in: PubMed   Mentions: 316     Fields:    Translation:HumansCellsCTClinical Trials
    241. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. J Nucl Med. 2005 Jan; 46(1):130-40. Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. PMID: 15632043.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    242. Gender: a major determinant of brain response to nicotine. Int J Neuropsychopharmacol. 2005 Mar; 8(1):17-26. Fallon JH, Keator DB, Mbogori J, Taylor D, Potkin SG. PMID: 15579215.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    243. Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. Schizophr Res. 2004 Feb 01; 66(2-3):101-13. Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ. PMID: 15061242.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    244. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull. 2004; 30(3):577-86. Alphs L, Anand R, Islam MZ, Meltzer HY, Kane JM, Krishnan R, Green AI, Potkin S, Chouinard G, Lindenmayer JP, Kerwin R. PMID: 15631247.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    245. Hostility differentiates the brain metabolic effects of nicotine. Brain Res Cogn Brain Res. 2004 Jan; 18(2):142-8. Fallon JH, Keator DB, Mbogori J, Turner J, Potkin SG. PMID: 14736573.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    246. Memory for emotional stimuli in patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2003 Nov-Dec; 18(6):340-2. Fleming K, Kim SH, Doo M, Maguire G, Potkin SG. PMID: 14682081.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    247. Alzheimer disease and other dementias. Clin Geriatr Med. 2003 Nov; 19(4):763-76. Alva G, Potkin SG. PMID: 15024811.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    248. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry. 2003 Aug 15; 54(4):444-52. Potkin SG, Alphs L, Hsu C, Krishnan KR, Anand R, Young FK, Meltzer H, Green A, InterSePT Study Group. PMID: 12915289.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    249. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2003 Jul; 60(7):681-90. Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR. PMID: 12860772.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansCTClinical Trials
    250. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial. Arch Neurol. 2003 Jun; 60(6):843-8. Farlow M, Potkin S, Koumaras B, Veach J, Mirski D. PMID: 12810489.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    251. Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. J Clin Psychiatry. 2003 May; 64(5):580-8. Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL. PMID: 12755663.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    252. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry. 2003 Apr; 160(4):741-8. Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K, Ziprasidone in Mania Study Group. PMID: 12668364.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    253. MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biol Psychiatry. 2003 Jan 01; 53(1):39-47. Molnar M, Potkin SG, Bunney WE, Jones EG. PMID: 12513943.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    254. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Mol Psychiatry. 2003 Jan; 8(1):109-13. Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE, Fallon JH, Kennedy JL. PMID: 12556915.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    255. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Curr Med Res Opin. 2003; 19(8):707-14. Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. PMID: 14687441.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    256. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003 Jan; 60(1):82-91. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group. PMID: 12511175.
      View in: PubMed   Mentions: 289     Fields:    Translation:HumansCTClinical Trials
    257. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Ther. 2002 Nov; 24(11):1809-23. Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C. PMID: 12501876.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    258. Brain metabolic effects of Neotrofin in patients with Alzheimer's disease. Brain Res. 2002 Sep 27; 951(1):87-95. Potkin SG, Alva G, Keator D, Carreon D, Fleming K, Fallon JH. PMID: 12231461.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    259. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry. 2002 Aug; 59(8):705-12. Albert KA, Hemmings HC, Adamo AI, Potkin SG, Akbarian S, Sandman CA, Cotman CW, Bunney WE, Greengard P. PMID: 12150646.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    260. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine. J Clin Psychopharmacol. 2002 Apr; 22(2):174-82. Potkin SG, Thyrum PT, Alva G, Carreon D, Yeh C, Kalali A, Arvanitis LA, Pharmacokinetic Study Group. PMID: 11910263.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    261. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. J Clin Psychopharmacol. 2002 Apr; 22(2):121-30. Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA. PMID: 11910256.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    262. The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients. Int Psychogeriatr. 2002; 14 Suppl 1:7-26. Potkin SG. PMID: 12636178.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    263. Stability of exploratory eye movements as a marker of schizophrenia--a WHO multi-center study. World Health Organization. Schizophr Res. 2001 Dec 01; 52(3):203-13. Kojima T, Matsushima E, Ohta K, Toru M, Han YH, Shen YC, Moussaoui D, David I, Sato K, Yamashita I, Kathmann N, Hippius H, Thavundayil JX, Lal S, Vasavan Nair NP, Potkin SG, Prilipko L. PMID: 11705714.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    264. Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol. 2001 Sep; 4(3):223-30. Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH. PMID: 11602028.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    265. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res. 2001 Aug 05; 103(1):1-14. Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW. PMID: 11472786.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    266. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia. Mol Psychiatry. 2001 Mar; 6(2):230-4. Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Petronis A, Kennedy JL. PMID: 11317228.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    267. Sex-related difference in amygdala activity during emotionally influenced memory storage. Neurobiol Learn Mem. 2001 Jan; 75(1):1-9. Cahill L, Haier RJ, White NS, Fallon J, Kilpatrick L, Lawrence C, Potkin SG, Alkire MT. PMID: 11124043.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    268. EEG resonant responses in schizophrenia: a photic driving study with improved harmonic resolution. Schizophr Res. 2000 Sep 01; 44(3):213-20. Jin Y, Castellanos A, Solis ER, Potkin SG. PMID: 10962223.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    269. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A. 2000 Aug 01; 97(16):9276-80. Popken GJ, Bunney WE, Potkin SG, Jones EG. PMID: 10908653; PMCID: PMC16858.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    270. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Mol Psychiatry. 2000 Jul; 5(4):410-7. Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL. PMID: 10889552.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    271. Relative sparing of emotionally influenced memory in Alzheimer's disease. Neuroreport. 2000 Mar 20; 11(4):653-5. Moayeri SE, Cahill L, Jin Y, Potkin SG. PMID: 10757495.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    272. An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. Am J Hum Genet. 2000 Mar; 66(3):819-29. Vincent JB, Neves-Pereira ML, Paterson AD, Yamamoto E, Parikh SV, Macciardi F, Gurling HM, Potkin SG, Pato CN, Macedo A, Kovacs M, Davies M, Lieberman JA, Meltzer HY, Petronis A, Kennedy JL. PMID: 10712198; PMCID: PMC1288165.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    273. Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry. 2000 Jan; 57(1):57-64. Patterson JV, Jin Y, Gierczak M, Hetrick WP, Potkin S, Bunney WE, Sandman CA. PMID: 10632233.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    274. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology. 1999 Jul; 21(1):17-27. Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, Potkin SG, Macciardi F, Kennedy JL. PMID: 10379516.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    275. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacology. 1999 May; 20(5):491-505. Daniel DG, Zimbroff DL, Potkin SG, Reeves KR, Harrigan EP, Lakshminarayanan M. PMID: 10192829.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    276. Structured Interview for Assessing Perceptual Anomalies (SIAPA). Schizophr Bull. 1999; 25(3):577-92. Bunney WE, Hetrick WP, Bunney BG, Patterson JV, Jin Y, Potkin SG, Sandman CA. PMID: 10478790.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    277. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. Am J Psychiatry. 1999 Jan; 156(1):145-7. Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B. PMID: 9892314.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    278. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):15066-71. Huntsman MM, Tran BV, Potkin SG, Bunney WE, Jones EG. PMID: 9844016; PMCID: PMC24576.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    279. Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry. 1998 Jun 15; 43(12):873-8. Jin Y, Bunney WE, Sandman CA, Patterson JV, Fleming K, Moenter JR, Kalali AH, Hetrick WP, Potkin SG. PMID: 9627741.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    280. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. Clin Electroencephalogr. 1998 Apr; 29(2):73-8. Jin Y, Potkin SG, Sandman CA, Bunney WE. PMID: 9571294.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    281. Bipolar affective disorder partially cosegregates with a balanced t(9;11)(p24;q23.1) chromosomal translocation in a small pedigree. Am J Med Genet. 1998 Feb 07; 81(1):81-91. Baysal BE, Potkin SG, Farr JE, Higgins MJ, Korcz J, Gollin SM, James MR, Evans GA, Richard CW. PMID: 9514593.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    282. Lateralized attentional deficits in drug-free and medicated schizophrenic patients. Neuropsychologia. 1997 Dec; 35(12):1519-25. Wigal SB, Swanson JM, Potkin SG. PMID: 9460721.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    283. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains. Brain Res. 1997 Aug 08; 765(1):7-12. Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG. PMID: 9310388.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    284. Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res. 1997 May 05; 70(2):71-81. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney WE. PMID: 9194201.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    285. REM sleep eye movement counts correlate with visual imagery in dreaming: a pilot study. Psychophysiology. 1997 May; 34(3):377-81. Hong CC, Potkin SG, Antrobus JS, Dow BM, Callaghan GM, Gillin JC. PMID: 9175452.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    286. Neuropathological studies of brain tissue in schizophrenia. J Psychiatr Res. 1997 Mar-Apr; 31(2):159-73. Bunney BG, Potkin SG, Bunney WE. PMID: 9278184.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    287. Electroencephalographic photic driving in patients with schizophrenia and depression. Biol Psychiatry. 1997 Feb 15; 41(4):496-9. Jin Y, Potkin SG, Sandman CA, Bunney WE. PMID: 9034545.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    288. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains. Eur J Pharmacol. 1996 Oct 31; 314(3):R3-5. Helmeste DM, Tang SW, Bunney WE, Potkin SG, Jones EG. PMID: 8957266.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    289. P50 changes with visual interference in normal subjects: a sensory distraction model for schizophrenia. Clin Electroencephalogr. 1996 Jul; 27(3):151-4. Jin Y, Potkin SG. PMID: 8828978.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    290. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 1996 May; 53(5):425-36. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG. PMID: 8624186.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCells
    291. Language in dreaming and regional EEG alpha power. Sleep. 1996 Apr; 19(3):232-5. Hong CC, Jin Y, Potkin SG, Buchsbaum MS, Wu J, Callaghan GM, Nudleman KL, Gillin JC. PMID: 8723382.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    292. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res. 1996 Mar; 19(1):41-53. Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Lohr J, Tang C, Wu J, Potkin SG. PMID: 9147495.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    293. New directions in the prevention and treatment of schizophrenia: a biological perspective. Psychiatry. 1996; 59(4):357-70. Wyatt RJ, Apud JA, Potkin S. PMID: 9029657.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    294. Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry. 1996 Jan 01; 39(1):51-8. Hetrick WP, Sandman CA, Bunney WE, Jin Y, Potkin SG, White MH. PMID: 8719126.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    295. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 1996 Jan; 16(1):19-30. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE, Jones EG. PMID: 8613785; PMCID: PMC6578738.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    296. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex. 1995 Nov-Dec; 5(6):550-60. Akbarian S, Huntsman MM, Kim JJ, Tafazzoli A, Potkin SG, Bunney WE, Jones EG. PMID: 8590827.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    297. Topographic analysis of EEG photic driving in normal and schizophrenic subjects. Clin Electroencephalogr. 1995 Apr; 26(2):102-7. Jin Y, Sandman CA, Wu JC, Bernat J, Potkin SG. PMID: 7781188.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    298. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995 Apr; 52(4):258-66. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG. PMID: 7702443.
      View in: PubMed   Mentions: 363     Fields:    Translation:HumansCells
    299. New morphological and neuropathological findings in schizophrenia: a neurodevelopmental perspective. Clin Neurosci. 1995; 3(2):81-8. Bunney BG, Potkin SG, Bunney WE. PMID: 7583623.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    300. Clozapine increases EEG photic driving in clinical responders. Schizophr Bull. 1995; 21(2):263-8. Jin Y, Potkin SG, Sandman C. PMID: 7631173.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    301. Patterns of cortical activity in schizophrenia. Psychol Med. 1994 Nov; 24(4):947-55. Schroeder J, Buchsbaum MS, Siegel BV, Geider FJ, Haier RJ, Lohr J, Wu J, Potkin SG. PMID: 7892362.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    302. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry. 1994 Sep; 55 Suppl B:133-6. Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B, et al. PMID: 7961557.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    303. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry. 1994 Sep; 55 Suppl B:63-6. Potkin SG, Buchsbaum MS, Jin Y, Tang C, Telford J, Friedman G, Lottenberg S, Najafi A, Gulasekaram B, Costa J, et al. PMID: 7961576.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    304. S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurol Scand Suppl. 1994; 154:15-8. Bell KM, Potkin SG, Carreon D, Plon L. PMID: 7941961.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    305. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry. 1993 Sep; 150(9):1325-36. Siegel BV, Buchsbaum MS, Bunney WE, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, et al. PMID: 8352343.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    306. Olfactory memory in unmedicated schizophrenics. Schizophr Res. 1993 Mar; 9(1):41-7. Wu J, Buchsbaum MS, Moy K, Denlea N, Kesslak P, Tseng H, Plosnaj D, Hetu M, Potkin S, Bracha S, et al. PMID: 8068050.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    307. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry. 1993 Mar; 50(3):169-77. Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG. PMID: 7679891.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    308. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry. 1993 Mar; 50(3):178-87. Akbarian S, Viñuela A, Kim JJ, Potkin SG, Bunney WE, Jones EG. PMID: 7679892.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    309. Measuring the psychological construct of control. Discriminant, divergent, and incremental validity of the Shapiro Control Inventory and Rotter's and Wallstons' Locus of Control Scales. Int J Psychosom. 1993; 40(1-4):35-46. Shapiro DH, Potkin SG, Jin Y, Brown B, Carreon D, Wu J. PMID: 8070984.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    310. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry. 1992 Dec; 49(12):966-74. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, Gulasekaram B, Marshall JF, Lottenberg S, Teng CY, et al. PMID: 1449383.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    311. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry. 1992 Dec; 49(12):935-42. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, et al. PMID: 1360198.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    312. A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J Neurosci Methods. 1992 Sep; 44(2-3):133-44. Jones EG, Hendry SH, Liu XB, Hodgins S, Potkin SG, Tourtellotte WW. PMID: 1282187.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    313. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology. 1992 May; 6(3):155-63. Buchsbaum MS, Potkin SG, Marshall JF, Lottenberg S, Teng C, Heh CW, Tafalla R, Reynolds C, Abel L, Plon L, et al. PMID: 1599606.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    314. PET studies of drug interaction with brain regional glucose metabolism. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:472A-473A. Buchsbaum MS, Potkin S, Siegel B, Bunney WE, Lohr J, Katz M, Gottschalk L, Lottenberg S, Teng C, Abel L. PMID: 1354054.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    315. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol. 1991; 6 Suppl:S119-27. Swanson JM, Posner M, Potkin S, Bonforte S, Youpa D, Fiore C, Cantwell D, Crinella F. PMID: 2002210.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    316. An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics. J Clin Psychopharmacol. 1990 Feb; 10(1):71-2. Costa J, Khaled E, Sramek J, Bunney W, Potkin SG. PMID: 2307738.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    317. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry. 1990 Feb; 156:216-27. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S. PMID: 2317626.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    318. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse. 1990; 6(2):146-53. O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF. PMID: 2237777.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    319. Abnormal EEG responses to photic stimulation in schizophrenic patients. Schizophr Bull. 1990; 16(4):627-34. Jin Y, Potkin SG, Rice D, Sramek J, Costa J, Isenhart R, Heh C, Sandman CA. PMID: 2077640.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    320. Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug tolerance. DICP. 1990 Jan; 24(1):7-10. Sramek JJ, Gaurano V, Herrera JM, Potkin SG. PMID: 1967862.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    321. EEG alpha photic driving abnormalities in chronic schizophrenia. Psychiatry Res. 1989 Dec; 30(3):313-24. Rice DM, Potkin SG, Jin Y, Isenhart R, Heh CW, Sramek J, Costa J, Sandman CA. PMID: 2616694.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    322. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia. Schizophr Res. 1989 Nov-Dec; 2(6):439-48. Guich SM, Buchsbaum MS, Burgwald L, Wu J, Haier R, Asarnow R, Nuechterlein K, Potkin S. PMID: 2487185.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    323. Limited eye movement patterns in chronic schizophrenic patients. Psychiatry Res. 1989 Jun; 28(3):307-14. Kojima T, Potkin SG, Kharazmi M, Matsushima E, Herrera J, Shimazono Y. PMID: 2569750.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    324. Serum homovanillic acid concentrations in carbamazepine-treated chronic schizophrenics. Biol Psychiatry. 1989 Mar 01; 25(5):639-41. Heh CW, Potkin SG, Pickar D, Costa J, Herrera J, Sramek J, DeMet E. PMID: 2920197.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    325. Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry. 1988 Oct; 145(10):1277-9. Hullett FJ, Potkin SG, Levy AB, Ciasca R. PMID: 2458683.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    326. S-adenosylmethionine treatment of depression: a controlled clinical trial. Am J Psychiatry. 1988 Sep; 145(9):1110-4. Bell KM, Plon L, Bunney WE, Potkin SG. PMID: 3046382.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    327. Rapid antidepressant response with SAMe. A double-blind study. Ala J Med Sci. 1988 Jul; 25(3):313-6. Potkin SG, Bell K, Plon L, Bunney WE. PMID: 3052140.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    328. Neuroleptic plasma concentrations and clinical response: in search of a therapeutic window. Drug Intell Clin Pharm. 1988 May; 22(5):373-80. Sramek JJ, Potkin SG, Hahn R. PMID: 2899021.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    329. Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacology. 1988 May; 1(2):149-56. Heh CW, Herrera J, DeMet E, Potkin S, Costa J, Sramek J, Hazlett E, Buchsbaum MS. PMID: 3251495.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    330. Aids-related complex presenting as psychosis. Am J Psychiatry. 1987 Jul; 144(7):964. Halevie-Goldman BD, Potkin SG, Poyourow P. PMID: 3605411.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    331. Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol. 1986; 9 Suppl 4:181-3. Potkin SG, Zetin M, Stamenkovic V, Kripke D, Bunney WE. PMID: 3567938.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    332. Evaluation of optimal doses of a neuroleptic: preliminary results. Clin Neuropharmacol. 1986; 9 Suppl 4:437-9. Potkin SG, Urbanchek MS, Kirch DG, Bunney WE. PMID: 2882848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    333. Plasma neuroleptic concentration: in search of a therapeutic window. Clin Neuropharmacol. 1986; 9 Suppl 4:256-8. Potkin S, Hahn R, Sramek J. PMID: 2882840.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    334. Eye movements in remitting and non-remitting schizophrenia. Clin Neuropharmacol. 1986; 9 Suppl 4:277-9. Kojima T, Matsushima E, Moriya H, Ando K, Takahashi R, Shimazono Y, Kharazmi M, Herrera J, Potkin S. PMID: 3567944.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    335. Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patients. Neuropeptides. 1985 Feb; 5(4-6):553-6. Zhang AZ, Zhou GZ, Xi GF, Gu NF, Xia ZY, Yao JL, Chang JK, Webber R, Potkin S. PMID: 2860611.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    336. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data. Psychopharmacol Bull. 1985; 21(1):59-61. Potkin SG, Shen YC, Zhou DF, Pardes H, Shu L, Phelps B, Poland R. PMID: 3983339.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    337. Haloperidol concentrations elevated in Chinese patients. Psychiatry Res. 1984 Jun; 12(2):167-72. Potkin SG, Shen Y, Pardes H, Phelps BH, Zhou D, Shu L, Korpi E, Wyatt RJ. PMID: 6591221.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    338. Amelioration of psychosis with carbidopa. A case report. Br J Psychiatry. 1984 Apr; 144:428-31. Linnoila M, Karoum F, Potkin SG, Wyatt RJ, Potter WZ. PMID: 6722403.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    339. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man. Biol Psychiatry. 1984 Feb; 19(2):165-78. Karoum F, Potkin S, Chuang LW, Murphy DL, Liebowitz MR, Wyatt RJ. PMID: 6713036.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    340. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity. Psychiatry Res. 1984 Feb; 11(2):91-7. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ. PMID: 6143337.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    341. Novel technique for collection and storage of biological samples. Lancet. 1983 Dec 03; 2(8362):1304. Potkin SG, Gu NF, Zhou DF. PMID: 6139641.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    342. Failure to isolate virus from CSF of schizophrenics. Lancet. 1983 Oct 15; 2(8355):919. Mered B, Albrecht P, Torrey EF, Weinberger DR, Potkin SG, Winfrey CJ. PMID: 6137739.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    343. Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia. Arch Gen Psychiatry. 1983 Jul; 40(7):749-52. Potkin SG, Cannon-Spoor HE, DeLisi LE, Neckers LM, Wyatt RJ. PMID: 6860076.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    344. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry. 1983 Jun; 140(6):754-7. Shore D, Potkin SG, Weinberger DR, Torrey EF, Henkin RI, Agarwal RP, Gillin JC, Wyatt RJ. PMID: 6133465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    345. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles. Am J Psychiatry. 1983 Jan; 140(1):21-5. Potkin SG, Weinberger DR, Linnoila M, Wyatt RJ. PMID: 6183980.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    346. Cerebrospinal fluid zinc concentrations in ex-heroin addicts and patients with schizophrenia: some preliminary observations. Biol Psychiatry. 1982 Nov; 17(11):1315-22. Potkin SG, Shore D, Torrey EF, Weinberger DR, Gillin JC, Henkin RI, Agarwal RP, Wyatt RJ. PMID: 6129905.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    347. The effect of oral glucose on platelet monoamine oxidase. Biol Psychiatry. 1982 Sep; 17(9):1011-5. Karson CN, Bridge TP, Phelps BH, Wise CD, Potkin SG, Apostoles PS, Wyatt RJ. PMID: 7138991.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    348. Ex uno multi: subtyping the schizophrenic syndrome. Biol Psychiatry. 1982 Feb; 17(2):199-222. Jeste DV, Kleinman JE, Potkin SG, Luchins DJ, Weinberger DR. PMID: 6122474.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    349. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982; 8(3):470-84. Cannon-Spoor HE, Potkin SG, Wyatt RJ. PMID: 7134891.
      View in: PubMed   Mentions: 254     Fields:    Translation:Humans
    350. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia. Psychiatry Res. 1981 Dec; 5(3):341-52. Jeste DV, Doongaji DR, Panjwani D, Datta M, Potkin SG, Karoum F, Thatte S, Sheth AS, Apte JS, Wyatt RJ. PMID: 6948314.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    351. Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br J Psychiatry. 1981 Dec; 139:513-8. Delisi LE, Weinberger DR, Potkin S, Neckers LM, Shiling DJ, Wyatt RJ. PMID: 7332855.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    352. Wheat gluten challenge in schizophrenic patients. Am J Psychiatry. 1981 Sep; 138(9):1208-11. Potkin SG, Weinberger D, Kleinman J, Nasrallah H, Luchins D, Bigelow L, Linnoila M, Fischer SH, Bjornsson TD, Carman J, Gillin JC, Wyatt RJ. PMID: 7270725.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    353. A biochemical study of tardive dyskinesia in young male patients. Psychiatry Res. 1981 Jun; 4(3):327-31. Jeste DV, DeLisi LE, Zalcman S, Wise CD, Phelps BH, Rosenblatt JE, Potkin SG, Bridge TP, Wyatt RJ. PMID: 6115438.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    354. Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia. Clin Genet. 1981 May; 19(5):437-42. Wyatt RJ, Karoum F, Stoff DM, Kleinman JE, Gillin JC, Jeste DV, Potkin SG. PMID: 7296934.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    355. The schizophrenia syndrome. Examples of biological tools for subclassification. J Nerv Ment Dis. 1981 Feb; 169(2):100-12. Wyatt RJ, Potkin SG, Kleinman JE, Weinberger DR, Luchins DJ, Jeste DV. PMID: 7009783.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    356. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia. J Clin Psychiatry. 1981 Feb; 42(2):75-7. Jeste DV, Neckers LM, Wagner RL, Wise CD, Staub RA, Rogol A, Potkin SG, Bridge TP, Wyatt RJ. PMID: 6109719.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    357. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients. Psychiatry Res. 1981 Feb; 4(1):95-107. DeLisi LE, Wise CD, Bridge TP, Rosenblatt JE, Wagner RL, Morihisa J, Karson C, Potkin SG, Wyatt RJ. PMID: 6111821.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    358. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings]. Psychopharmacol Bull. 1981 Jan; 17(1):103-4. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ. PMID: 7232634.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    359. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia. Biol Psychiatry. 1980 Dec; 15(6):895-907. DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ. PMID: 7459411.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    360. Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia. Am J Psychiatry. 1980 Nov; 137(11):1410-3. Weinberger DR, Cannon-Spoor E, Potkin SG, Wyatt RJ. PMID: 6969033.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    361. Wheat gluten and haloperidol. Biol Psychiatry. 1980 Oct; 15(5):819-21. Luchins DJ, Freed WJ, Potkin S, Rosenblatt JE, Gillin JC, Wyatt RJ. PMID: 7417635.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    362. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients. Biol Psychiatry. 1980 Apr; 15(2):329-32. Freed WJ, Kleinman JE, Karson CN, Potkin SG, Murphy DL, Wyatt RJ. PMID: 7417620.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    363. Monoamine oxidase in schizophrenia: an overview. Schizophr Bull. 1980; 6(2):199-207. Wyatt RJ, Potkin SG, Bridge TP, Phelps BH, Wise CD. PMID: 7375851.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    364. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. Psychopharmacol Bull. 1980 Jan; 16(1):52-4. Potkin SG, Wyatt RJ, Karoum F. PMID: 7360842.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    365. Sources of error in the determination of platelet monoamine oxidase: a review of methods. Schizophr Bull. 1980; 6(2):245-53. Wise CD, Potkin SG, Bridge TP, Phelps BH, Cannon-Spoor H, Wyatt RJ. PMID: 7375857.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    366. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science. 1979 Oct 26; 206(4417):479-81. Kleinman JE, Potkin S, Rogol A, Buchsbaum MS, Murphy DL, Gillin JC, Nasrallah HA, Wyatt RJ. PMID: 504993.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    367. Phenylethylamine in paranoid chronic schizophrenia. Science. 1979 Oct 26; 206(4417):470-1. Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Phillips I, Wyatt RJ. PMID: 504988.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    368. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Psychiatry Res. 1979 Oct; 1(2):187-90. Wise CD, Bridge TP, Potkin SG, Wyatt RJ. PMID: 298348.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    369. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia. Psychiatry Res. 1979 Oct; 1(2):179-85. Kobes RD, Potkin SG, Wise CD, Bridge TP, Neckers LM, Wyatt RJ. PMID: 298347.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    370. An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate. Am J Psychiatry. 1979 Oct; 136(10):1336-7. Wise CD, Potkin S, Bridge P, Wyatt RJ. PMID: 484736.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    371. Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain. J Neurochem. 1979 Jul; 33(1):201-12. Karoum F, Nasrallah H, Potkin S, Chuang L, Moyer-Schwing J, Phillips I, Wyatt RJ. PMID: 458449.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    372. Tardive dyskinesia--reversible and persistent. Arch Gen Psychiatry. 1979 May; 36(5):585-90. Jeste DV, Potkin SG, Sinha S, Feder S, Wyatt RJ. PMID: 35116.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    373. Platelet monoamine oxidase activity in schizophrenia: a review of the data. Am J Psychiatry. 1979 Apr; 136(4A):377-85. Wyatt RJ, Potkin SG, Murphy DL. PMID: 371419.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    374. Are paranoid schizophrenics biologically different from other schizophrenics? N Engl J Med. 1978 Jan 12; 298(2):61-6. Potkin SG, Cannon HE, Murphy DL, Wyatt RJ. PMID: 619236.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    375. Baclofen: lack of effect on human plasma prolactin. Commun Psychopharmacol. 1978; 2(4):297-300. Potkin SG, Gillin JC, Rogol A, Nasrallah HA, Wyatt RJ. PMID: 729355.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    376. Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res. 1977 Apr 15; 125(2):333-9. Karoum F, Moyer-Schwing J, Potkin SG, Wyatt RJ. PMID: 856412.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    377. Suicide prevention centers. Ecological study of effectiveness. J Nerv Ment Dis. 1977 Jan; 164(1):18-24. Bridge TP, Potkin SG, Zung WW, Soldo BJ. PMID: 830797.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Steven's Networks
    Concepts (816)
    Derived automatically from this person's publications.
    _
    Co-Authors (98)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _